IBD patients in KELA-register

K11_KELAIBD

inflammatory bowel disease: A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — 208\|209 1 out of 7 registries used, show all original rules.	11298
4. Check minimum number of events None	11298
5. Include endpoints None	11298
6. Filter based on genotype QC (FinnGen only)	11298

Control definitions (FinnGen only)

Control exclude: K11_ENERCOLNONINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF3

NAME	K11_KELAIBD
CONTROL_EXCLUDE	K11_ENERCOLNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	208\|209
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to IBD patients in KELA-register based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64105	29608	34206
Only index persons	60335	28315	32020
Unadjusted period prevalence (%)
Whole population	0.90	0.85	0.96
Only index persons	1.14	1.04	1.22
Median age at first event (years)
Whole population	37.43	36.66	37.96
Only index persons	36.55	36.07	36.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11298	5907	5391
Unadjusted period prevalence (%)	2.19	2.01	2.38
Median age at first event (years)	38.38	35.81	41.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10091: Matched controls
100910

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D94

ICPC

Chronic enteritis/ulcerative colitis

354.5

323.0

762

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

16384.0

323.0

3026

A07EA06

ATC

budesonide; oral, local oral

272.9

323.0

4063

250

A07EA02

ATC

hydrocortisone; rectal

302.2

323.0

3088

147

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

+∞

323.0

420

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

+∞

323.0

344

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

5040.3

323.0

4718

A07EC02

ATC

mesalazine; oral, rectal

2116.5

323.0

8850

339

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

299.4

323.0

563

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

134.8

323.0

389

K50.1

ICD-10 Finland

Crohn disease of large intestine

7340.2

323.0

1845

H02AB06

ATC

prednisolone; systemic

7.6

323.0

7628

29233

UJF32

NOMESCO Finland

Coloscopy

21.3

323.0

7274

10900

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

59.5

323.0

610

109

ZX120

NOMESCO Finland

Intravenous

5.3

323.0

1756

3832

K50.0

ICD-10 Finland

Crohn disease of small intestine

6155.9

323.0

2030

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

323.0

355

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

323.0

10091

J01MA02

ATC

ciprofloxacin; systemic

3.0

323.0

4713

22621

H02AB07

ATC

prednisone; oral

6.1

323.0

2906

6227

A07EA01

ATC

prednisolone; rectal

449.5

323.0

636

UJF30

NOMESCO Finland

Ileoscopy through colon

21.9

323.0

4229

3217

L01BB02

ATC

mercaptopurine; oral

211.3

323.0

1275

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2704.0

323.0

2006

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

323.0

3783

14442

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

82.5

323.0

597

K50.9

ICD-10 Finland

Crohn disease, unspecified

4961.2

323.0

2054

UJF92

NOMESCO Finland

Capsular endoscopy

25.1

323.0

954

418

K51.5

ICD-10 Finland

Left sided colitis

5382.1

323.0

4757

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

10.3

323.0

2266

2760

K51.8

ICD-10 Finland

Other ulcerative colitis

2988.1

323.0

2030

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.5

323.0

4302

14214

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

+∞

323.0

1465

L04AB04

ATC

adalimumab; parenteral

15.7

323.0

886

616

P01AB01

ATC

metronidazole; oral, rectal

3.0

323.0

5023

24905

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

+∞

323.0

316

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

+∞

323.0

1155

K51

ICD-10 Finland

Ulcerative colitis

1108.3

323.0

1263

K50.8

ICD-10 Finland

Other Crohn disease

16384.0

323.0

2376

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

41.0

323.0

1309

365

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

3959.2

323.0

1096

4AA12

NOMESCO Finland

133.7

323.0

361

K50

ICD-10 Finland

Crohn disease [regional enteritis]

1132.3

323.0

434

A07EC01

ATC

sulfasalazine; oral, rectal

9.1

323.0

2409

3363

L04AX01

ATC

azathioprine; systemic

89.0

323.0

4491

900

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

53.4

323.0

613

122

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

258.3

318.0

325

4AB02

NOMESCO Finland

74.4

308.5

353

A07EC03

ATC

olsalazine; oral

2806.1

293.9

283

WX002

NOMESCO Finland

Sedation and analgesia

2.8

293.2

2266

9453

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

493.5

290.9

289

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

+∞

288.9

276

K83.0

ICD-10 Finland

Cholangitis

18.2

288.9

460

264

C10AC01

ATC

colestyramine; oral

10.1

288.6

601

631

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

286.0

2425

10674

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

262.3

2460

11383

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

261.8

4167

24926

A02BC02

ATC

pantoprazole; systemic

2.1

261.2

6300

44840

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

+∞

258.4

247

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

247.2

2153

9516

JF1BD

NOMESCO Finland

Very extensive small bowel CT

41.8

244.0

308

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

222.8

1333

4608

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

3.3

222.7

1267

4225

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

7.8

218.3

528

709

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.3

212.8

691

1373

A05AA02

ATC

ursodeoxycholic acid; oral

9.5

212.8

455

498

L04AC05

ATC

ustekinumab; parenteral

42.3

209.8

264

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

34.3

200.4

264

A07DA03

ATC

loperamide; oral

6.0

189.0

554

970

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

185.5

3699

23276

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.9

183.8

814

2202

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

182.8

1123

3924

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

11.1

181.8

357

332

1370

FHL

Colonoscopy, whole colon

32.2

174.3

233

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.2

171.5

705

1779

3042

Kela drug reimbursment

+∞

164.0

157

253

Kela drug reimbursment

+∞

161.9

155

4AA33

NOMESCO Finland

+∞

154.5

148

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

147.2

141

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.3

145.4

581

1423

Z93.2

ICD-10 Finland

Ileostomy status

56.7

145.3

173

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

+∞

143.0

137

L04AD01

ATC

ciclosporin; systemic

6.3

138.8

386

629

JF1AD

NOMESCO Finland

Small bowel CT

24.5

135.8

195

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

+∞

135.7

130

C05AA08

ATC

fluocortolone; rectal, topical

2.3

134.4

1437

6833

JFH10

NOMESCO Finland

Total colectomy and ileostomy

77.3

133.7

152

JFB20

NOMESCO Finland

Ileocaecal resection

23.0

132.5

194

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

12.5

131.5

243

199

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

651.6

130.8

129

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

+∞

128.4

123

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

7.3

127.5

321

455

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

20.0

126.7

194

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

123.9

1288

6026

K92.1

ICD-10 Finland

Melaena

3.8

120.3

542

1475

5550A

ICD-9 Finland

Regional enteritis, Small intestine

+∞

117.9

113

JFH11

NOMESCO Finland

Laparoscopic colectomy

+∞

116.9

112

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.4

116.0

1129

5101

N02BE01

ATC

paracetamol; systemic, rectal

1.8

115.1

8082

70187

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

114.7

1338

6586

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

12.4

112.4

208

171

JFB00

NOMESCO Finland

Partial resection of small intestine

7.7

112.1

270

358

K60.3

ICD-10 Finland

Anal fistula

5.6

110.7

338

619

H02AB09

ATC

hydrocortisone; systemic

4.9

108.7

375

789

3AC01

NOMESCO Finland

8.7

108.4

242

284

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.4

108.4

567

1740

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

276.6

107.1

109

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

533.6

106.9

106

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

106.8

697

2500

N02AX02

ATC

tramadol; systemic, rectal

1.6

106.2

3651

25974

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

40.0

105.6

134

A02BC03

ATC

lansoprazole; oral

1.7

104.1

2462

15709

5551A

ICD-9 Finland

Regional enteritis, Large intestine

+∞

103.3

JFF10

NOMESCO Finland

Loop enterostomy

17.7

102.9

164

B03BA03

ATC

hydroxocobalamin; parenteral

3.4

102.9

533

1623

UJF02

NOMESCO Finland

Peroral enteroscopy

17.3

102.1

164

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

7.1

101.9

260

376

A02BC01

ATC

omeprazole; systemic

1.8

101.6

2340

14792

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

260.6

100.9

103

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.0

99.2

334

684

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

96.8

1246

6366

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

250.0

96.8

JHA00

NOMESCO Finland

Anal or perianal incision

6.1

95.6

272

456

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.7

95.1

341

747

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.3

94.8

302

581

K56.7

ICD-10 Finland

Ileus, unspecified

7.6

92.9

225

301

WVA20

NOMESCO Finland

Medicine administration

4.8

90.5

318

682

L04AA33

ATC

vedolizumab; parenteral

+∞

88.7

A07AA09

ATC

vancomycin; oral

8.4

88.3

201

244

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

87.1

1934

11996

H02AB04

ATC

methylprednisolone; systemic

2.0

86.8

1308

7096

K51.4

ICD-10 Finland

Inflammatory polyps

855.8

86.8

M45

ICD-10 Finland

Ankylosing spondylitis

4.2

85.2

341

832

K61.0

ICD-10 Finland

Anal abscess

4.9

83.5

284

588

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

83.3

716

3011

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

82.1

2416

16227

A02BC05

ATC

esomeprazole; systemic

1.5

80.8

3415

25102

3005

Kela drug reimbursment

Tofacitinib

20.7

80.4

121

L04AB06

ATC

golimumab; parenteral

8.0

79.8

187

238

R50.9

ICD-10 Finland

Fever, unspecified

1.9

78.9

1308

7333

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.2

77.7

251

491

J01MA12

ATC

levofloxacin; systemic

1.8

77.7

1515

8980

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.3

77.2

301

717

Z2221

NOMESCO Finland

Medical doctor

1.6

75.2

2528

17508

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

+∞

75.1

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.3

73.6

202

324

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

38.0

73.5

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.1

73.4

420

1372

ZXE00

NOMESCO Finland

One hour or less

1.5

73.3

3526

26528

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

+∞

73.0

K59.1

ICD-10 Finland

Functional diarrhoea

2.9

72.8

471

1673

6419

FHL

Other measure in this category

51.6

72.3

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

8.8

71.3

157

181

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

69.3

3376

25383

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

16.8

68.1

110

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

66.7

UJK12

NOMESCO Finland

Peroral cholangioscopy

23.9

66.2

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

6.1

64.5

183

307

1490

FHL

Sigmoideoscopy (fiberscope)

19.2

64.3

UJG02

NOMESCO Finland

Proctoscopy

4.2

64.0

252

606

J01DB01

ATC

cefalexin; oral

1.5

63.5

7759

69564

B01AB05

ATC

enoxaparin; parenteral

1.6

63.5

2256

15722

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

63.4

526

2161

B81

ICPC

Anaemia vit B12/folate deficiency

3.4

63.3

322

965

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

+∞

61.5

JFF13

NOMESCO Finland

Terminal enterostomy

25.5

61.1

L04AA29

ATC

tofacitinib; oral

15.2

60.2

101

WW200

NOMESCO Finland

Immunization

3.2

60.0

338

1093

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

+∞

59.4

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.0

59.3

853

4511

JAH00

NOMESCO Finland

Laparotomy

3.6

59.2

281

797

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

58.9

614

2829

UJK02

NOMESCO Finland

ERCP

4.0

58.6

245

623

UJF34

NOMESCO Finland

Left colonoscopy

9.0

58.1

126

142

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

153.4

57.9

D11

ICPC

Diarrhoea

1.8

57.8

1082

6277

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

12.8

57.2

103

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

32.8

57.0

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.7

56.5

411

1565

107

Kela drug reimbursment

Pernicious anaemia

4.9

56.5

190

390

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

56.2

3992

31952

UJD02

NOMESCO Finland

Gastroscopy

2.6

56.2

421

1634

WX402

NOMESCO Finland

General anaesthesia

1.6

55.5

1488

9609

A06AC51

ATC

ispaghula, combinations; systemic

2.6

55.4

439

1759

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

55.4

1474

9497

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

55.3

3134

24016

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

54.7

565

2592

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

17.7

54.4

TJF80

NOMESCO Finland

Ostomy education

6.6

54.3

143

218

D16

ICPC

Rectal bleeding

3.8

54.0

238

635

E0000UV

ATC

1.4

52.0

3402

26707

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

51.9

1081

6478

L04AA01

ATC

[U] ciclosporin; systemic

4.4

51.1

193

447

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

14.4

50.8

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

50.8

278

881

Z93

ICD-10 Finland

Artificial opening status

16.2

50.3

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

256.7

50.1

D06BX01

ATC

metronidazole; topical

1.8

49.9

861

4849

M05BA04

ATC

alendronic acid; oral

2.3

49.3

466

2048

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.7

49.1

224

616

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

49.0

1718

11832

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

48.7

777

4258

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

15.1

48.4

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

62.5

48.2

6403

FHL

Ileocal resection

77.6

47.9

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

47.9

367

1442

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.4

45.6

231

691

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

20.7

45.6

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

45.6

590

2982

UJF30

SPAT

8.7

45.5

100

116

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

45.1

3297

26221

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

44.5

431

1917

K56.0

ICD-10 Finland

Paralytic ileus

6.9

44.4

113

165

D07AC01

ATC

betamethasone; topical

1.4

44.1

2733

21089

ZXD05

NOMESCO Finland

Urgent procedure

1.4

44.1

2631

20165

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

43.8

627

3296

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.6

43.5

343

1371

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

429.5

43.2

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

4.3

43.1

164

384

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

43.0

712

3945

UJH02

NOMESCO Finland

Anoscopy

2.4

42.8

376

1590

1380

FHL

Colonoscopy, left side

43.5

42.2

A02BA02

ATC

ranitidine; systemic

1.6

42.1

1352

9084

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

92.5

41.8

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

40.9

2831

22211

4AC05

NOMESCO Finland

+∞

40.6

D18

ICPC

Change in faeces/bowel movements

3.3

40.2

211

650

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

40.2

688

3855

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.3

40.1

153

359

JHD20

NOMESCO Finland

Incision of fistula-in-ano

4.6

40.1

142

310

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

88.4

39.8

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

11.4

39.7

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

+∞

39.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

39.2

831

4988

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

22.5

38.7

JF2AB

NOMESCO Finland

Colongraphy with X-ray

12.4

38.5

6410

FHL

Panprococolectomy and ileostomy

+∞

37.5

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.5

37.4

114

211

Z3231

NOMESCO Finland

Registered nurse

1.4

37.2

2140

16203

J01FA10

ATC

azithromycin; systemic

1.3

36.9

5367

46908

E86

ICD-10 Finland

Volume depletion

3.6

36.7

170

475

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

17.9

36.5

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

5.1

36.5

117

230

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

35.2

475

2440

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

9.2

35.0

D01

ICPC

Abdominal pain/cramps general

1.6

34.7

882

5568

C05AA01

ATC

hydrocortisone; rectal, topical

2.2

34.6

387

1837

SPAT1263

SPAT

Sampling

1.3

34.4

3518

29151

Z94.4

ICD-10 Finland

Liver transplant status

8.8

34.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

33.8

235

874

K76.9

ICD-10 Finland

Liver disease, unspecified

3.8

33.7

148

396

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

33.7

459

2365

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

8.9

33.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

33.3

3535

29405

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

7.4

32.9

107

J02AC01

ATC

fluconazole; systemic

1.3

32.8

3179

26085

J05AB11

ATC

valaciclovir; oral

1.6

32.5

999

6615

L88

ICD-10 Finland

Pyoderma gangrenosum

14.2

32.3

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.7

32.2

146

402

D07AC13

ATC

mometasone; topical

1.4

32.2

2267

17698

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.1

32.1

103

203

ZX112

NOMESCO Finland

Subcutaneous

3.0

32.0

190

639

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

31.7

301

1327

D99

ICPC

Disease digestive system other

4.4

31.6

116

264

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

13.2

31.3

A07AA02

ATC

nystatin; oral

2.0

30.4

418

2163

JH1CM

NOMESCO Finland

Perianal extensive MRI with 3 Tesla magnet

21.0

29.9

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

155.4

29.7

JHD00

NOMESCO Finland

Anal dilatation

5.0

29.7

196

6402

FHL

Small bowel resection

20.1

29.5

SPAT1262

SPAT

Handing over of treatment supplies

1.5

29.3

1235

8762

E000001

ATC

1.4

29.2

1667

12528

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

+∞

29.2

5589X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis

+∞

29.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

28.9

1202

8502

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

28.4

682

4233

6525

FHL

Enterostomy occlusion

21.7

28.2

6408

FHL

Colectomy and ileostomy

+∞

28.1

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

28.1

224

904

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.2

28.1

150

471

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

28.0

426

2286

K61.1

ICD-10 Finland

Rectal abscess

7.3

27.8

JJC00

NOMESCO Finland

Allogenic transplantation of liver

10.0

27.6

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

27.4

7737

82020

D07AD01

ATC

clobetasol; topical

1.5

27.3

1123

7922

5604

FHL

Vascular preparation or cannulation in the operating room

12.4

26.7

M81.4

ICD-10 Finland

Drug-induced osteoporosis

9.5

26.3

Z43.2

ICD-10 Finland

Attention to ileostomy

15.4

26.3

J05AB01

ATC

aciclovir; systemic

1.4

26.0

1570

11891

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

7.4

26.0

SPAT1255

SPAT

Intravenous administration of medicine

1.8

25.8

459

2602

WZC30

NOMESCO Finland

Teaching

1.5

25.7

934

6413

JFA60

NOMESCO Finland

Stricturoplasty in small intestine

261.3

25.7

J01AA02

ATC

doxycycline; systemic

1.3

25.7

6586

60407

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

25.6

2166

17295

J01DA01

ATC

[U] cefalexin; systemic

1.2

25.6

5368

48073

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

25.6

646

4062

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

25.4

215

895

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.2

25.3

232

SPAT1131

SPAT

Colonoscopy

2.4

25.2

226

970

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

25.1

25.2

B80

ICPC

Iron deficiency anaemia

2.8

25.2

162

577

B02.9

ICD-10 Finland

Zoster without complication

1.9

25.1

358

1879

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

24.8

1725

13359

K62.4

ICD-10 Finland

Stenosis of anus and rectum

11.0

24.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

24.7

2693

22257

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

130.3

24.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

24.6

910

6272

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

24.5

2649

21870

R01AD12

ATC

fluticasone furoate; nasal

1.3

24.4

2552

20967

JFB30

NOMESCO Finland

Right hemicolectomy

3.8

24.3

105

280

Y0599

ICD-8 Finland

Investigation of digestive system

3.1

24.2

134

433

A01AB09

ATC

miconazole; local oral

1.7

24.1

569

3510

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

24.1

348

1835

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

24.0

650

4160

R01AD08

ATC

fluticasone; nasal

1.3

24.0

2334

18980

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

7.1

24.0

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

24.0

983

6922

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.2

23.9

221

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

23.4

519

3149

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.7

23.4

164

615

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

23.3

494

2960

K60.4

ICD-10 Finland

Rectal fistula

9.6

23.2

ZXC86

NOMESCO Finland

Use of endoscopic device

5.2

23.1

139

D07XC01

ATC

betamethasone, combinations; topical

1.5

23.0

850

5851

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

23.0

277

1363

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

22.4

2432

20034

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.5

22.3

105

301

L52

ICD-10 Finland

Erythema nodosum

4.5

22.1

177

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

22.1

249

1189

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

12.6

22.0

R11

ICD-10 Finland

Nausea and vomiting

1.6

22.0

554

3479

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

16.0

21.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

21.8

1251

9376

B04AD01

ATC

13.7

21.7

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

21.4

512

3173

K63.2

ICD-10 Finland

Fistula of intestine

16.2

21.3

D29

ICPC

Digestive symptom/complaint other

2.6

21.3

152

579

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.1

21.3

238

1134

J01CA04

ATC

amoxicillin; systemic

1.3

21.2

7529

70704

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

21.2

111

346

RD210

NOMESCO Finland

2.5

21.1

170

693

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

21.1

4006

35176

6455

FHL

Perianal fistula surgery

6.0

21.1

J01FA06

ATC

roxithromycin; oral

1.2

20.7

3123

26720

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

76.9

20.7

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

20.4

154

606

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

20.3

483

2987

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.4

20.3

114

L01BB01

ATC

9.6

20.2

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

13.0

20.1

S18

ICPC

Laceration/cut

1.2

19.9

3019

25821

UJF32

SPAT

2.8

19.7

130

472

JF1CD

NOMESCO Finland

Extensive small bowel CT

73.6

19.7

1470

FHL

Rectoscopy

4.7

19.6

144

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

8.0

19.6

WW500

NOMESCO Finland

Blood transfusion

2.0

19.6

258

1318

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

19.6

222

1068

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.5

19.6

150

597

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.2

19.5

102

318

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

19.5

2181

17985

UKC02

NOMESCO Finland

Cystoscopy

1.4

19.3

909

6566

R01AD09

ATC

mometasone; nasal

1.2

19.3

3770

33106

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

19.3

469

2919

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

19.2

1658

13207

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.8

19.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

19.1

550

3572

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

16.7

19.1

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

9.3

19.0

K85

ICD-10 Finland

Acute pancreatitis

2.7

19.0

131

491

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

18.9

1387

10792

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

18.9

318

1773

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.0

18.9

228

1125

K65.0

ICD-10 Finland

Acute peritonitis

3.4

18.9

278

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

10.6

18.8

WX110

NOMESCO Finland

Local anesthesy

1.2

18.8

6218

57478

B01AB10

ATC

tinzaparin; parenteral

1.7

18.7

429

2626

M25.5

ICD-10 Finland

Pain in joint

1.3

18.7

2136

17650

JFB96

NOMESCO Finland

Other partial excision of intestine

20.8

18.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

18.5

713

4946

WX004

NOMESCO Finland

Patient-controlled sedation

4.7

18.4

136

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

18.4

948

6963

N03AX16

ATC

pregabalin; oral

1.3

18.3

1597

12732

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

6.9

18.3

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

18.3

230

1153

K30

ICD-10 Finland

Functional dyspepsia

1.5

18.3

697

4830

M03BX02

ATC

tizanidine; oral

1.2

18.1

5308

48403

K29.8

ICD-10 Finland

Duodenitis

3.8

18.0

201

C10AC02

ATC

colestipol; oral

8.3

17.9

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

17.8

181

830

6522

FHL

Ileostomy

+∞

17.7

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

17.7

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.2

17.6

188

882

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

17.5

348

2047

ICD-10 Finland

2.2

17.5

174

788

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

17.5

160

696

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.9

17.5

108

379

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

1.9

17.4

253

1341

6404

FHL

Hemicolectomy on the right

13.1

17.4

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

17.3

375

2263

N05CF01

ATC

zopiclone; oral

1.3

17.3

2109

17536

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

17.3

106

370

JFA70

NOMESCO Finland

Suture of small intestine

6.7

17.2

K83.1

ICD-10 Finland

Obstruction of bile duct

3.2

17.1

289

SPAT1325

SPAT

Vaccination

1.2

17.1

2283

19184

J01FA09

ATC

clarithromycin; systemic

1.2

17.1

2497

21195

A02BA03

ATC

famotidine; systemic

2.0

17.0

218

1100

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

17.0

211

1052

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.9

17.0

104

362

4AA17

NOMESCO Finland

50.1

17.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

16.9

280

1555

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.8

16.8

183

SPAT1153

SPAT

Removal of sutures

1.2

16.8

2167

18127

56398

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Alia definita

+∞

16.7

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.2

16.7

169

776

R10.0

ICD-10 Finland

Acute abdomen

2.0

16.6

218

1114

5609X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction

9.7

16.6

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

16.6

223

1148

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

4.3

16.5

143

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

16.5

616

4248

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

16.3

16.5

5781A

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[MELAENA]

8.2

16.4

R03AC02

ATC

salbutamol; inhalant

1.2

16.4

4291

38563

K63.9

ICD-10 Finland

Disease of intestine, unspecified

6.5

16.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

16.2

344

2061

R4190

NOMESCO Finland

Nutritional therapy

1.8

16.1

262

1449

Z93.3

ICD-10 Finland

Colostomy status

3.9

16.1

171

JFA76

NOMESCO Finland

Closure of fistula of small intestine

30.0

16.1

JJ5AT

NOMESCO Finland

13.5

15.9

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

2.3

15.8

146

640

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

5.2

15.8

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

15.7

2072

17354

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

4.7

15.7

114

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

2.9

15.7

319

A98

ICPC

Health maint/preventive medicine

1.4

15.7

9456

92224

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

15.6

528

3565

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

3.7

15.6

181

K90.0

ICD-10 Finland

Coeliac disease

2.0

15.5

208

1071

JK3MN

NOMESCO Finland

Bile absorbtion isotope examination

38.1

15.4

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.9

15.3

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

15.3

621

4354

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

15.3

1127

8758

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

5474

34845

2.11

317.05

2.4

2.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

466

670

7.21

307.95

1.5

1.2

titre

264.2

159.8

1.70

173

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2740

11249

2.90

307.65

2.7

2.4

g/l

2.4

5.38

2616

10489

(3022948) Iron [Moles/volume] in Serum or Plasma

2902

12244

2.84

307.65

2.8

2.4

umol/l

13.2

14.0

5.57

2788

11449

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1942

7153

3.07

307.65

3.7

2.3

g/l

0.2

15.92

1850

6669

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5389

19105

4.48

307.65

4.0

2.0

mg/l

2.8

0.80

4961

16377

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

894

2128

4.48

307.65

1.2

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

8464

42385

4.97

307.65

13.9

5.6

57.4

56.6

10.48

8228

39894

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

766

193

42.50

307.65

2.7

1.3

mg/l

9.5

8.9

0.68

650

149

(3021440) Promyelocytes/100 leukocytes in Blood

2526

6393

4.80

307.65

6.4

4.1

0.1

2.48

664

1629

(3024561) Albumin [Mass/volume] in Serum or Plasma

8960

33280

9.18

307.65

9.8

4.6

g/l

37.0

36.2

37.84

8725

30987

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6661

40151

2.61

307.65

4.0

2.8

ug/l

98.0

115.7

6.52

6390

37769

(3013707) Erythrocyte sedimentation rate by Westergren method

9704

64700

4.54

307.65

7.6

3.6

mm/h

11.4

10.3

16.09

9313

60461

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

341

+∞

307.65

2.4

0.0

mg/l

3.2

—

331

(3006315) Basophils [#/volume] in Blood

9086

44020

6.43

307.65

14.6

5.6

e9/l

0.0

3.27

8535

38312

(3021589) Normoblasts [#/volume] in Blood

6943

39312

2.99

307.65

17.2

8.6

e9/l

0.0

1.57

6259

32125

(3048689) Calprotectin [Mass/mass] in Stool

9129

9864

44.00

307.65

7.7

1.3

ug/g

226.8

88.9

141.17

8767

7415

(3017181) Myelocytes/100 leukocytes in Blood

2617

6710

4.77

307.65

6.3

4.1

0.7

0.9

2.96

707

1751

(3034770) Mitochondria Ab [Titer] in Serum

1190

2431

5.35

307.65

1.7

1.2

titre

520.0

1026.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10899

92754

5.96

307.65

26.0

11.6

mg/l

15.2

22.6

181.39

9788

71607

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

235

35.27

307.65

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1132

1706

7.26

307.65

3.4

6.3

iu/ml

698.3

1625.4

0.48

119

237

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5397

30145

2.51

307.65

4.9

3.2

u/l

30.0

33.8

4.84

4997

28714

(3005719) IgG [Mass/volume] in Serum or Plasma

1839

6682

3.09

307.65

2.6

2.5

g/l

11.5

10.5

22.44

1713

6129

(40760892) CBC W Ordered Manual Differential panel - Blood

4659

20781

3.11

307.65

10.6

4.0

—

(3025159) Blasts/100 leukocytes in Blood

2419

6083

4.79

307.65

6.5

4.2

0.0

0.2

1.10

570

1381

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

869

1991

4.65

307.65

1.3

u/ml

279.1

253.0

1.47

514

1277

(3022096) Basophils/100 leukocytes in Blood

8326

39858

5.14

307.65

14.6

5.8

0.7

31.45

8084

37342

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2604

2509

13.19

307.65

1.8

1.6

iu/ml

3.1

10.8

0.54

563

512

(3013650) Neutrophils [#/volume] in Blood by Automated count

9360

50587

5.96

307.65

16.2

8.9

e9/l

3.9

4.0

10.10

8803

44268

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2676

10359

3.07

307.65

2.7

2.5

22.1

24.0

8.45

2352

8972

(42870588) Differential panel, method unspecified - Blood

7115

28816

4.97

307.65

12.7

5.7

—

(3037522) Nuclear Ab [Titer] in Serum

2672

12515

2.49

307.65

1.7

1.3

titre

553.2

548.8

0.04

726

2327

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

574

163

37.05

307.65

2.1

1.3

au/ml

93.5

200.3

1.09

(3013115) Eosinophils [#/volume] in Blood

9182

45609

6.41

307.65

14.7

5.9

e9/l

0.2

7.58

8650

40385

(3017143) Hepatitis C virus Ab [Presence] in Serum

3305

13078

3.16

307.65

1.5

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4663

25959

2.36

307.65

4.2

2.5

u/l

58.8

57.4

0.89

4424

24078

(3019198) Lymphocytes [#/volume] in Blood

9120

45507

6.21

307.65

14.6

5.6

e9/l

1.9

2.0

14.68

8621

40409

(3001604) Monocytes [#/volume] in Blood

9068

43848

6.41

307.65

14.5

5.6

e9/l

0.6

3.55

8510

38180

(3022145) Colonoscopy Study observation

7145

7661

23.65

307.65

2.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3813

18297

2.64

307.65

1.6

1.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1144

116

109.62

307.65

2.9

2.0

au/ml

131.0

212.3

0.86

157

(3002179) Metamyelocytes/100 leukocytes in Blood

2496

6133

4.94

307.65

5.9

3.9

0.3

0.6

7.65

546

1270

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3465

4506

10.65

307.65

2.1

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

8454

41435

5.13

307.65

14.8

6.0

8.7

8.4

15.58

8220

39031

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

796

1575

5.36

307.65

1.6

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6761

42747

2.45

307.65

7.6

6.0

umol/l

10.6

11.2

3.83

6509

40466

(3028026) IgM [Mass/volume] in Serum or Plasma

1602

5094

3.50

307.65

1.9

1.8

g/l

1.2

1.3

1.14

1509

4693

(3006504) Eosinophils/100 leukocytes in Blood

8422

41204

5.10

307.65

14.5

5.7

2.8

2.9

4.19

8184

38584

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1087

897

13.30

307.65

1.2

1.1

iu/ml

1.8

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8149

34011

6.01

307.65

3.9

2.1

nmol/l

74.4

74.5

0.15

7922

31205

(3007566) Smooth muscle Ab [Titer] in Serum

1212

2480

5.35

307.65

1.7

1.2

titre

71.8

130.4

1.49

124

238

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

583

750

8.14

307.65

2.0

1.2

titre

—

(3002030) Lymphocytes/100 leukocytes in Blood

8507

43032

4.95

307.65

14.6

5.7

28.5

28.9

3.20

8266

40350

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10533

65352

10.03

307.65

18.2

6.8

u/l

74.3

76.1

5.62

10380

61737

(3025941) Bacteria identified in Stool by Culture

1883

4989

4.33

307.65

1.5

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1302

111

132.45

307.65

3.5

2.2

mg/l

8.6

6.1

4.02

1097

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

465

670

7.20

306.68

1.5

1.2

titre

317.6

164.0

0.62

(3003327) Ova and parasites identified in Stool by Light microscopy

1037

3059

3.63

294.25

1.8

1.7

—

(40758558) Short blood count panel - Blood

3801

21893

2.11

278.21

10.9

6.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

744

1823

4.30

273.64

1.4

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

498

876

5.90

270.08

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

503

895

5.84

269.53

1.7

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

496

874

5.89

268.50

1.7

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3328

18528

2.13

263.80

1.7

1.4

g/l

2.5

2.3

3.61

2429

11790

(3014148) Varicella zoster virus Ab [Titer] in Serum

638

1442

4.63

259.95

1.1

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

482

870

5.74

254.28

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

483

875

5.72

253.81

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

482

877

5.70

252.10

1.7

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

625

1427

4.58

251.35

2.2

1.5

g/l

0.8

0.01

509

1085

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

644

1518

4.44

248.70

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4800

31043

1.95

246.27

2.2

1.8

pmol/l

93.5

97.1

6.71

3074

16626

(3048929) Epstein Barr virus Ab [Presence] in Serum

1072

3628

3.16

242.76

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5636

38592

1.92

242.11

7.0

6.7

mmol/l

1.2

1.88

4737

32731

(46235355) HIV 1 and 2 tests - Meaningful Use set

3813

22978

2.00

238.67

1.8

2.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2451

12583

2.21

235.14

2.1

1.7

nmol/l

1158.1

1162.3

0.07

1728

9774

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

760

2114

3.78

233.92

1.8

1.4

iu/ml

5.1

14.3

2.06

(40768797) Stomach Pathology biopsy report

2216

10958

2.27

232.75

1.3

1.2

—

(3032080) INR in Blood by Coagulation assay

4697

30686

1.91

228.96

8.3

7.6

inr

1.1

1.2

11.35

1666

9254

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

868

2692

3.41

226.35

2.0

1.6

titre

529.5

278.9

1.52

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

515

1103

4.84

223.71

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2882

16019

2.07

223.44

2.4

1.6

pmol/l

23295444.5

31042732.3

0.37

2610

13662

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10050

85679

2.57

218.34

20.1

10.6

ml/min/173m2

90.3

87.9

24.24

8865

70196

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5126

34885

1.86

216.07

6.2

6.0

mmol/l

1.2

4.09

4729

31877

(3009445) Proteinase 3 Ab [Units/volume] in Serum

984

3397

3.08

214.51

1.8

1.5

u/ml

5.6

15.5

2.55

108

(42529406) Shigella sp [Presence] in Stool by Culture

765

2383

3.37

197.50

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

762

2368

3.38

197.47

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

756

2346

3.38

196.34

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

362

655

5.68

190.12

2.4

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

106

59.44

189.89

1.1

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

385

748

5.29

187.02

1.3

1.2

u/l

59.3

63.7

0.40

266

498

(3023368) Bacteria identified in Blood by Culture

3318

20402

1.89

186.14

4.7

4.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10931

99032

4.19

182.47

22.9

8.9

u/l

27.1

28.0

5.18

10846

96032

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

964

3627

2.81

178.80

1.2

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

7592

60194

1.80

175.71

4.7

3.9

—

(3018418) pH of Serum or Plasma

3552

22653

1.83

175.25

4.2

4.1

7.4

0.20

705

4433

(40761536) Microorganisms panel - Urine sediment

1547

7352

2.28

174.53

4.2

3.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

464

1125

4.26

172.04

4.1

2.9

u/ml

11.1

227.7

1.06

455

1047

(3002385) Erythrocyte distribution width [Ratio]

9298

78984

2.00

167.76

27.2

14.3

13.7

13.5

23.74

9246

77401

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1854

9656

2.10

165.43

4.1

2.8

umol/l

6.4

8.0

3.99

1631

8357

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

708

2402

3.08

157.88

5.3

3.5

u/ml

48.0

2459.3

1.37

630

2056

(40768441) Liver Pathology biopsy report

302

568

5.44

151.96

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1572

7933

2.14

151.31

3.4

2.5

u/l

40.2

45.7

0.38

1410

6806

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

295

559

5.39

147.21

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3275

21292

1.76

146.01

1.3

u/ml

1.3

1.8

1.72

834

6067

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

294

564

5.33

144.71

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

3314

21696

1.75

143.73

5.8

3.8

94.6

92.2

7.44

3230

21152

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

250

428

5.95

139.02

1.4

1.2

u/l

77.1

84.4

0.54

208

372

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

244

411

6.05

137.96

1.4

1.2

u/l

20.8

18.9

0.18

204

353

(3004809) Band form neutrophils/100 leukocytes in Blood

436

1187

3.78

137.51

3.0

3.3

1.0

1.5

2.56

321

924

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

438

1220

3.69

133.58

1.1

g/l

1.5

0.21

411

1100

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1612

8647

2.01

130.14

1.3

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

10203

91858

2.14

124.49

18.5

13.1

mmol/l

139.5

139.7

17.62

9997

89522

(3023103) Potassium [Moles/volume] in Serum or Plasma

10230

92198

2.16

124.39

18.6

13.2

mmol/l

3.9

4.0

55.92

10008

89659

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

236

432

5.56

122.27

1.8

1.5

u/l

5.2

5.3

0.04

140

197

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

123

105

11.83

121.05

2.3

1.6

mg/l

2.1

1.6

1.95

107

(3009261) Glucose [Presence] in Urine by Test strip

5625

43495

1.58

120.29

3.9

3.2

estimate

0.0

0.37

1643

7833

(3035350) Ketones [Presence] in Urine by Test strip

5571

43022

1.58

119.49

3.9

3.2

estimate

0.0

1.54

1637

7852

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

189

287

6.68

118.33

1.7

u/ml

4922.1

14867.0

0.34

(3029937) Albumin [Presence] in Urine by Test strip

3318

22667

1.66

118.12

4.3

3.6

estimate

0.0

0.46

1648

7807

(3021601) Nitrite [Presence] in Urine by Test strip

5567

43145

1.57

116.37

5.0

4.4

estimate

0.0

1.84

1685

8138

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

278

633

4.48

111.57

1.8

1.3

umol/l

10.9

12.0

2.51

273

597

(3021960) Folate [Moles/volume] in Serum or Plasma

2604

16914

1.70

111.24

1.6

1.5

nmol/l

20.3

20.2

0.13

2346

14798

(3013826) Glucose [Moles/volume] in Serum or Plasma

6172

49373

1.55

109.11

5.2

4.6

mmol/l

6.5

6.6

2.23

5819

45630

(3017354) Segmented neutrophils/100 leukocytes in Blood

293

716

4.17

107.27

3.0

3.3

58.2

56.4

0.61

178

458

(3017732) Neutrophils [#/volume] in Blood

1195

6194

2.04

104.76

2.9

2.6

e9/l

4.2

4.1

0.82

871

5056

(3010375) cycloSPORINE [Mass/volume] in Blood

211

403

5.32

104.33

18.1

27.3

ug/l

130.0

117.2

1.61

192

323

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4481

33740

1.54

101.88

4.0

3.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1460

8208

1.89

100.77

2.2

nmol/l

331.6

372.2

13.97

1358

7564

(3041096) Erythrocytes [Presence] in Urine by Automated

3431

24426

1.58

99.47

3.6

2.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1016

5058

2.11

99.06

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1396

7877

1.88

94.88

3.7

2.7

1.8

1.7

1.41

1274

7049

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

227

504

4.58

94.03

1.1

miu/ml

1565.9

1501.7

0.32

227

504

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

604

2488

2.51

91.99

1.2

1.3

—

(40761511) CBC panel - Blood by Automated count

10534

97898

2.12

88.26

19.2

10.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

529

2112

2.58

85.95

1.3

1.5

u/ml

22.3

20.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

530

2123

2.57

85.52

1.3

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

248

642

3.93

83.91

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

248

649

3.88

82.64

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1223

6928

1.86

81.36

4.8

4.1

ug/l

16.5

30.4

0.77

956

5479

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

490

1945

2.59

80.51

1.4

1.5

u/ml

106.8

111.0

0.40

101

400

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

243

5.95

80.15

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

257

708

3.69

79.54

1.1

—

(3008898) HLA-B27 [Presence]

770

3758

2.13

78.50

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

268

769

3.55

78.04

3.3

4.0

—

(3052851) Hemolysis interference index of Serum or Plasma

555

2370

2.41

77.99

3.2

3.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

105

132

8.02

77.81

1.5

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

1044

5703

1.92

77.56

2.8

2.6

e9/l

73.9

70.9

1.45

818

4233

(3031040) Bacteria [#/volume] in Urine by Automated count

6669

56298

1.45

76.78

4.5

3.9

e6/l

1007.4

1201.2

0.08

722

(3042936) Bacteria identified in Isolate by Culture

1806

11728

1.64

73.43

2.2

2.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

384

1427

2.75

71.88

2.6

3.1

u/ml

852.4

1319.3

0.30

(3014576) Chloride [Moles/volume] in Serum or Plasma

1522

9516

1.69

71.46

8.4

7.5

mmol/l

104.8

104.5

2.06

1503

9318

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

375

1386

2.76

70.93

4.9

3.5

u/ml

103.8

546.0

1.61

342

1277

(3002582) Erythrocytes [#/volume] in Urine

3300

24803

1.47

68.34

3.4

3.0

e6/l

62.4

79.2

0.44

2695

18818

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

148

306

4.89

66.89

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

148

306

4.89

66.89

1.5

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

3040

22633

1.47

65.55

3.3

3.0

e6/l

0.4

0.60

2424

16804

(3000850) Epithelial cells [#/volume] in Urine

2393

16989

1.52

65.18

2.7

2.5

e6/l

5.7

5.6

0.11

2156

14852

(3007461) Platelets [#/volume] in Blood

11010

105544

2.69

63.40

35.0

17.2

e9/l

271.8

253.7

137.71

10932

103122

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

167

400

4.22

62.84

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

848

4626

1.90

62.79

1.1

titre

41.0

240.2

—

147

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1575

10249

1.62

62.62

6.4

6.3

mmol/l

1.0

1.91

1491

9636

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

168

408

4.16

62.07

1.4

—

(3035941) MCH [Entitic mass]

11011

105643

2.66

61.72

34.8

17.1

30.4

30.2

18.65

10974

104426

(36304419) Bacteria [Presence] in Urine

2983

22341

1.46

61.63

3.2

2.9

—

(3024731) MCV [Entitic volume]

11011

105654

2.66

61.50

34.8

17.1

91.3

90.3

90.54

10974

104435

(3026361) Erythrocytes [#/volume] in Blood

11011

105670

2.65

61.19

34.9

17.2

e12/l

4.5

4.6

50.63

10916

103034

(3044640) Blood type and Crossmatch panel - Blood

3480

26862

1.43

60.90

2.8

2.3

—

(3010813) Leukocytes [#/volume] in Blood

11012

105704

2.65

60.80

35.0

17.2

e9/l

6.8

6.7

8.00

10920

103032

(3000963) Hemoglobin [Mass/volume] in Blood

11011

105716

2.64

60.28

35.1

17.2

g/l

136.1

137.9

33.23

10972

104484

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

374

1502

2.54

59.89

1.2

titre

136.0

210.9

—

(3026782) Osmolality of Urine

2209

15676

1.51

59.56

2.9

2.6

mosm/kgh2o

551.7

556.1

0.38

1959

13372

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

254

5.01

58.69

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

143

323

4.47

58.06

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4995

41285

1.38

57.37

4.7

3.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

470

2132

2.26

57.28

1.5

1.4

ug/g

288.3

278.3

0.46

269

1203

(3018095) Leukocytes [#/volume] in Urine

3754

29604

1.40

57.27

3.8

3.5

e6/l

66.9

75.8

0.24

2860

20465

(3013005) Retinol [Moles/volume] in Serum or Plasma

155

384

4.08

55.79

2.3

1.8

umol/l

2.1

1.9

1.08

148

360

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

231

746

3.14

55.71

1.1

mg/l

285.2

284.9

0.02

210

674

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

508

2454

2.12

52.86

3.8

4.2

mg/l

1.4

0.31

472

2296

(3032057) Clostridioides difficile [Presence] in Stool

129

6.55

52.11

2.1

1.9

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

146

365

4.04

51.93

1.1

u/l

22.0

24.5

0.11

124

279

(3020779) Urea [Moles/volume] in Serum or Plasma

1101

6876

1.67

50.86

8.6

8.2

mmol/l

8.5

8.9

1.24

1049

6603

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1738

12080

1.52

50.84

1.9

1.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

145

368

3.98

50.53

1.1

u/l

74.9

89.6

0.78

130

290

(4035726)

1092

6817

1.67

50.51

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1825

12855

1.50

50.00

4.3

3.6

mmol/l

0.8

7.00

1699

12114

(3015377) Calcium [Moles/volume] in Serum or Plasma

3344

26352

1.38

49.47

3.3

mmol/l

2.3

2.4

3.37

2979

23457

(3009871) Measles virus Ab [Titer] in Serum

140

353

4.00

49.24

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3670

29435

1.37

48.39

3.3

3.1

ng/l

39.2

70.2

0.91

2207

17468

(3019225) pH of Specimen

1133

7272

1.62

46.77

4.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2655

20435

1.39

44.36

2.8

2.2

—

(3020393) Adenovirus Ag [Presence] in Stool

8.21

43.97

1.6

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7397

66401

1.33

42.68

4.5

2.9

u/l

50.8

44.4

7.91

7036

62993

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1197

7950

1.57

42.54

3.3

3.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

366

1703

2.19

41.88

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

123

320

3.88

41.48

3.6

2.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1992

14746

1.43

41.28

1.3

u/ml

7.4

11.0

2.04

763

6092

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

577

3180

1.86

41.04

1.8

g/l

1.4

1.5

0.39

507

2755

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2506

19415

1.37

39.48

1.9

1.8

mg/l

1.1

0.45

1889

14418

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

963

6247

1.59

37.69

3.7

mmol/l

1.2

0.48

849

5512

(3007853) Bacteria identified in Skin by Aerobe culture

1435

10182

1.47

36.94

1.8

1.7

—

(3002032) Base excess in Venous blood by calculation

1045

6953

1.55

36.58

4.9

4.2

mmol/l

1.5

1.8

1.97

846

5674

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

348

1685

2.10

35.98

1.1

—

(3026008) Bacteria identified in Urine by Culture

2752

21901

1.34

35.83

3.0

2.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1237

8598

1.49

35.21

3.6

4.5

u/l

223.2

237.4

4.29

1179

8179

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

500

2773

1.84

34.82

1.6

1.7

g/l

1.2

0.04

476

2651

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

486

2682

1.85

34.39

1.6

1.8

g/l

0.2

1.16

461

2558

(4062490)

229

949

2.44

34.38

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

229

951

2.44

34.23

1.2

1.3

g/l

0.4

0.10

139

666

(3027135) IgG subclass 1 [Mass/volume] in Serum

229

951

2.44

34.23

1.2

1.3

g/l

7.8

6.6

3.30

142

666

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2044

15634

1.38

34.19

1.3

iu/ml

21.4

30.4

2.42

626

4805

(3028192) IgG subclass 2 [Mass/volume] in Serum

229

952

2.43

34.15

1.2

1.3

g/l

3.2

3.0

1.20

139

671

(3015171) Extractable nuclear Ab [Units/volume] in Serum

599

3538

1.73

33.69

1.3

1.2

u/ml

0.3

1.0

3.59

304

(3020717) Zinc [Moles/volume] in Serum or Plasma

139

450

3.11

33.54

1.8

1.5

umol/l

22.3

25.5

0.60

132

428

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1034

6994

1.53

33.45

5.0

4.2

kpa

5.8

5.9

0.83

1002

6773

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

178

674

2.67

32.26

1.1

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

487

2747

1.81

32.09

1.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

9453

89221

1.36

31.22

22.6

12.5

40.3

40.6

4.83

7088

70350

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

200

4.17

31.16

1.2

—

(3000494) Fungus identified in Specimen by Culture

1399

10210

1.42

30.56

1.6

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

477

2727

1.78

30.04

2.0

ug/l

5.1

2.2

0.47

429

2437

(3052592) Norovirus Ag [Presence] in Stool

111

5.34

29.84

1.8

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1248

9039

1.43

28.31

19.3

20.0

inr

1.2

1.3

1.13

235

1406

(36660697) Celiac disease serology panel - Serum

1077

7616

1.46

27.77

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1778

13756

1.35

26.94

2.9

2.6

e6/l

0.9

1.0

0.35

1073

7655

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1143

8237

1.43

26.58

1.8

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

470

2774

1.72

26.49

1.1

u/ml

4.9

5.5

0.08

434

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1132

8162

1.43

26.23

1.8

1.7

—

(40768443) Skin Pathology biopsy report

571

3591

1.62

25.24

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1658

12898

1.33

23.95

3.1

2.8

e6/l

2.8

2.6

0.39

957

6832

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

338

1871

1.83

23.73

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

599

3879

1.57

23.41

5.4

4.6

mmol/l

23.8

24.1

1.34

565

3491

(3000991) Gas panel - Venous blood

927

6582

1.44

23.25

9.5

9.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

784

5415

1.48

22.68

4.1

4.2

ng/l

86.6

89.5

0.35

707

4796

(3024354) Oxygen [Partial pressure] in Venous blood

813

5705

1.46

21.67

4.2

3.6

kpa

4.6

4.7

0.85

785

5505

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

393

2342

1.70

21.42

2.5

2.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

717

5000

1.46

19.72

7.4

7.7

mmol/l

24.4

24.7

1.26

706

4971

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

277

1541

1.82

19.21

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

666

4602

1.48

19.20

2.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

698

4876

1.46

19.02

4.4

3.5

kpa

5.0

5.2

5.08

644

4542

(40761535) Cells panel - Urine sediment

867

6320

1.40

18.68

3.5

3.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7521

70349

1.21

18.66

3.4

3.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2544

21505

1.24

18.34

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

313

1837

1.72

18.09

1.7

—

(3009343) pH of Capillary blood

685

4816

1.45

18.05

4.5

3.5

7.4

0.29

100

606

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

916

6783

1.38

17.96

3.0

2.5

ml/min/173m2

71.7

71.5

0.05

371

2530

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

489

3216

1.54

17.87

2.1

2.0

—

(3013512) EKG study

2577

21892

1.23

17.62

3.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

917

6814

1.38

17.59

7.5

7.7

mmol/l

1.3

0.36

876

6564

(3034274) Bile acid [Moles/volume] in Serum --fasting

275

1571

1.77

17.49

2.5

2.3

umol/l

12.6

6.2

2.93

213

1160

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

239

1312

1.84

17.35

1.8

—

(3002256) Pathology report gross observation

1374

10886

1.30

16.98

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

449

2935

1.55

16.87

2.0

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

791

5780

1.40

16.78

2.3

2.5

g/l

67.0

66.8

0.21

743

5355

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

174

870

2.02

16.71

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

657

4655

1.44

16.60

4.5

3.4

mmol/l

1.4

1.6

0.68

482

3419

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

235

1302

1.82

16.58

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

285

2.82

16.52

2.0

3.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

128

572

2.25

16.43

3.0

2.5

94.2

97.2

0.45

122

532

(44816559) Phosphatidylethanol [Mass/volume] in Blood

342

2115

1.64

16.25

1.2

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

304

1830

1.68

16.04

1.2

1.3

u/ml

6.1

5.2

0.10

132

(3004616) Nuclear Ab [Presence] in Serum

193

1016

1.92

15.99

1.3

—

(3012501) Base excess in Blood by calculation

299

1803

1.68

15.69

3.4

3.8

mmol/l

2.4

0.08

200

1182

(3013290) Carbon dioxide [Partial pressure] in Blood

299

1804

1.68

15.66

3.4

3.8

kpa

5.0

0.45

289

1772

(1616796) Gas panel - Central venous blood

293

1760

1.68

15.60

3.1

3.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

545

3782

1.46

15.39

1.7

2.0

u/l

37.9

39.4

1.00

479

3427

(3011412) CD3 cells [#/volume] in Blood

175

904

1.95

15.36

1.8

2.5

e9/l

1.1

1.2

0.17

526

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

194

1038

1.88

15.32

1.7

1.5

—

(3051651) Icteric interference index of Serum or Plasma

114

501

2.29

15.25

3.7

3.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2314

19700

1.22

15.15

3.7

3.3

—

(3010421) pH of Blood

336

2108

1.61

15.09

3.3

3.9

7.4

0.19

289

1773

(3027315) Oxygen [Partial pressure] in Blood

298

1815

1.66

15.07

3.4

3.9

kpa

8.9

8.8

0.73

288

1782

(3002173) Hemoglobin [Mass/volume] in Arterial blood

928

7096

1.34

14.73

8.9

8.6

g/l

121.1

123.4

2.70

897

6841

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1493

12185

1.26

14.39

2.4

2.2

29.9

29.7

0.91

1448

11840

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1616

13314

1.25

14.34

3.1

2.9

mmol/l

2.4

1.02

1404

11659

(3005322) IgE [Units/volume] in Serum or Plasma

826

6233

1.35

14.33

1.3

u/ml

229.6

232.4

0.02

768

5777

(3026493) Urate [Moles/volume] in Serum or Plasma

2578

22285

1.20

14.29

2.7

2.5

umol/l

3751.4

3555.5

0.10

2328

19757

(3026389) Candida sp identified in Specimen by Organism specific culture

222

1270

1.76

14.14

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

151

769

1.98

13.85

3.7

3.5

—

(3019150) Specific gravity of Urine by Refractometry

2211

18888

1.21

13.82

4.1

3.5

kg/l

1.0

0.30

324

2682

(3016502) Oxygen saturation in Arterial blood

981

7632

1.31

13.78

8.5

8.3

96.5

95.9

3.15

943

7352

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

635

4632

1.39

13.61

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

281

1732

1.64

13.60

3.6

3.0

umol/l

31.5

35.0

2.51

248

1501

(3042733) HLA Ab [Presence] in Serum

358

2.44

13.55

3.0

4.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

245

2.75

13.26

3.1

3.8

50.1

51.7

0.26

238

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

254

1538

1.67

13.19

1.1

u/ml

2.0

3.3

2.42

101

833

(3028433) Virus identified in Specimen by Culture

303

2.55

13.19

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

333

2.47

13.15

2.7

3.6

—

(40767503) Oxygen content in Capillary blood by calculation

268

1647

1.64

13.14

2.3

2.4

16.8

0.03

134

827

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7421

70166

1.17

13.13

3.7

3.8

pmol/l

14.7

14.6

6.76

6835

64782

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2746

24037

1.19

13.05

2.1

u/l

196.0

218.9

0.35

2621

22726

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.91

13.04

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

344

2248

1.55

13.02

1.3

u/ml

6.1

6.0

0.02

218

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

348

2283

1.54

12.95

1.3

u/ml

9.7

8.5

0.18

354

(3036071) Salmonella sp Ab [Titer] in Serum

325

2.47

12.83

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

373

2491

1.51

12.78

1.3

u/ml

28.1

38.5

0.37

154

(3047181) Lactate [Moles/volume] in Blood

368

2453

1.52

12.72

6.6

5.8

mmol/l

1.3

0.16

322

2157

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

349

2301

1.53

12.70

3.6

u/ml

0.3

0.25

185

1290

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

179

996

1.81

12.57

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1525

12671

1.24

12.40

1.5

1.4

—

(3003396) Base excess in Arterial blood by calculation

1073

8561

1.28

12.40

8.1

7.8

mmol/l

0.6

0.9

1.71

834

6665

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

115

553

2.09

12.40

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

158

850

1.87

12.37

1.7

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2176

18739

1.20

12.32

2.9

3.0

ng/l

1314.9

1131.6

0.96

1812

15694

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

202

1175

1.73

12.20

1.5

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

477

3377

1.43

12.16

4.2

3.5

mmol/l

24.8

25.2

2.20

461

3269

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8706

83558

1.18

12.13

4.4

4.5

mu/l

1.7

2.1

5.82

8125

77904

(3026250) Tacrolimus [Mass/volume] in Blood

102

473

2.17

12.09

41.8

36.7

ug/l

7.1

7.5

1.77

437

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1069

8565

1.27

11.93

8.1

7.8

kpa

5.0

5.1

3.31

1021

8209

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

133

684

1.96

11.93

1.8

2.8

e6/l

650.4

759.1

1.01

270

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

134

691

1.95

11.93

1.9

2.7

e6/l

433.1

520.1

1.43

116

568

(3008152) Bicarbonate [Moles/volume] in Arterial blood

619

4598

1.37

11.89

7.2

7.1

mmol/l

24.1

24.5

1.85

579

4277

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

111

536

2.08

11.86

1.5

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1068

8563

1.27

11.85

8.1

7.8

kpa

12.8

0.17

1021

8203

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

399

2745

1.47

11.84

3.1

2.9

g/l

3.4

3.6

1.19

377

2599

(3015235) Bicarbonate [Moles/volume] in Capillary blood

294

1896

1.57

11.84

4.0

3.1

mmol/l

24.0

24.6

1.54

253

1663

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

354

2387

1.50

11.62

1.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

206

1229

1.69

11.38

1.8

mmol/l

1.8

1.7

0.49

201

1204

(3004119) Hemoglobin [Mass/volume] in Venous blood

604

4502

1.36

11.36

4.1

3.5

g/l

130.6

131.6

0.43

582

4397

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

691

5257

1.33

11.35

1.0

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

565

4185

1.37

11.07

1.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

1385

1.64

11.04

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.81

10.93

1.0

1.1

—

(3022313) Gas panel - Capillary blood

484

3509

1.40

10.81

4.9

3.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

416

2938

1.43

10.78

6.3

5.2

0.9

0.65

393

2743

(3034860) Kappa light chains.free [Mass/volume] in Serum

302

2002

1.52

10.78

2.9

3.3

mg/l

47.5

53.0

0.51

239

1617

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

125

653

1.92

10.76

1.7

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

125

653

1.92

10.76

1.7

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

125

653

1.92

10.76

1.7

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

438

3129

1.42

10.66

4.7

3.9

47.7

50.4

1.49

432

3088

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

420

2981

1.42

10.60

6.2

5.1

1.7

0.50

398

2777

(3028626) Oxygen [Partial pressure] in Capillary blood

280

1833

1.54

10.60

5.4

3.4

kpa

8.7

8.6

0.47

259

1705

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

127

671

1.90

10.58

1.9

2.7

e9/l

0.1

0.2

6.89

115

564

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

301

2004

1.52

10.54

2.9

3.3

mg/l

36.7

51.3

1.14

237

1623

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

178

2.82

10.49

3.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

241

2.54

10.45

1.4

1.5

ug/l

10.6

8.8

1.55

241

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

117

604

1.95

10.45

1.2

u/ml

9.2

10.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

293

1947

1.52

10.36

2.9

3.2

ratio

1.4

2.5

0.97

168

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

120

628

1.92

10.30

1.2

u/ml

13.0

44.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

375

2624

1.44

10.24

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

211

1308

1.62

10.10

1.8

1.7

—

(3019060) Gas panel - Arterial blood

623

4762

1.33

9.93

5.4

4.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

236

1510

1.57

9.91

2.7

3.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1752

15066

1.19

9.87

3.3

3.4

ng/l

553.7

541.5

0.03

1170

10539

(3036489) Thrombin time

467

3424

1.38

9.78

2.2

2.3

21.4

21.1

0.32

403

2949

(3001186) Copper [Moles/volume] in Serum or Plasma

244

2.47

9.71

1.4

1.3

umol/l

16.5

16.8

0.13

209

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

415

2991

1.40

9.63

2.4

2.5

93.4

92.9

0.15

388

2780

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

424

3093

1.39

9.18

5.0

3.7

mmol/l

24.6

24.7

0.49

398

2885

(3030981) Hyaline casts [#/volume] in Urine by Automated count

544

4131

1.33

9.10

2.9

2.6

e6/l

0.4

0.3

0.65

530

4000

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

148

2.84

9.03

1.7

1.6

ug/l

0.4

0.47

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

380

2736

1.40

8.90

2.6

2.7

185.2

180.1

0.55

359

2602

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

156

2.76

8.77

2.7

2.8

mg/l

67.8

43.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

129

2.95

8.74

5.5

ug/min

36.5

41.2

0.24

(3035947) Staphylolysin Ab [Units/volume] in Serum

414

2.04

8.63

1.1

iu/ml

2.8

3.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

402

2.05

8.55

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

402

2.05

8.55

1.8

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

402

2.05

8.55

1.8

2.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

616

4803

1.30

8.54

9.7

10.0

94.7

94.0

3.57

609

4790

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

403

2.04

8.49

1.8

2.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

140

822

1.71

8.33

1.8

2.4

49.6

41.9

1.09

112

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

1076

1.62

8.26

1.6

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.08

8.24

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

452

3392

1.35

8.22

3.7

3.1

0.7

0.80

439

3252

(3018405) Lactate [Moles/volume] in Arterial blood

353

2553

1.40

8.09

3.7

4.1

mmol/l

1.4

0.03

342

2515

(3042631) Mycobacterium sp identified in Specimen

150

905

1.67

8.08

3.1

2.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.38

8.05

2.0

umol/l

1.2

1.3

1.50

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

333

2387

1.41

8.04

1.8

2.1

mg/l

10.7

10.5

0.18

304

2243

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

593

7513

0.78

8.00

1.3

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

542

4195

1.31

7.95

11.5

10.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.84

7.84

1.1

1.0

—

(3003181) Sodium [Moles/volume] in Urine

178

1134

1.58

7.72

1.8

1.4

mmol/l

65.8

65.4

0.04

114

911

(3045414) Leukocytes [Presence] in Urine

495

3800

1.32

7.72

1.9

1.8

—

(3021901) Oxygen saturation in Capillary blood

204

1343

1.53

7.66

3.8

2.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

177

1131

1.57

7.59

1.2

1.3

u/ml

5.3

63.0

—

(3044889) 12 lead EKG panel

6327

60176

1.12

7.56

3.4

3.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2635

1.37

7.41

2.3

2.1

g/l

4.0

3.8

1.24

257

1921

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2637

1.37

7.38

2.3

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2639

1.37

7.35

2.3

2.1

g/l

7.1

7.3

0.80

264

2025

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

147

906

1.63

7.34

1.6

1.7

—

(3045424) Erythrocytes [Presence] in Urine

213

1429

1.50

7.33

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

195

1284

1.53

7.33

2.5

—

(3039000) Anion gap in Blood

247

1711

1.45

7.24

8.3

6.9

mmol/l

11.6

11.2

1.10

227

1531

(3018572) Chloride [Moles/volume] in Blood

247

1712

1.45

7.22

8.3

6.9

mmol/l

105.4

105.3

0.16

227

1532

(3024471) HLA-A [Type]

353

2.02

7.19

1.0

—

(3003338) MCHC [Mass/volume]

8621

83575

1.13

7.15

28.0

14.7

g/l

332.3

333.6

35.18

8598

82972

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

184

1208

1.53

7.03

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

393

1.94

6.91

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

220

2.28

6.91

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

333

2452

1.37

6.91

2.3

2.2

g/l

10.7

10.2

0.82

282

2102

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

598

4788

1.26

6.76

9.8

10.0

0.7

1.47

592

4758

(3024932) HLA-DR beta [Type]

348

1.99

6.75

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

263

2.13

6.63

1.3

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

102

589

1.74

6.54

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

161

1046

1.55

6.49

7.1

6.8

mg/l

11.7

10.9

1.34

151

974

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

217

1503

1.45

6.42

3.4

3.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

304

4083

0.74

6.34

1.5

1.7

mg/l

3.3

3.6

0.51

213

2804

(44790047)

147

942

1.57

6.31

1.6

—

(44790049)

147

942

1.57

6.31

1.6

—

(44806118)

147

942

1.57

6.31

1.6

—

(44790048)

147

942

1.57

6.31

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

266

1918

1.40

6.30

1.2

1.3

u/ml

30.8

42.7

0.59

182

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

594

4795

1.25

6.28

9.7

9.9

1.3

1.4

2.02

587

4767

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

379

2890

1.32

6.27

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

334

2502

1.35

6.24

2.3

2.2

g/l

3.1

3.0

1.14

262

1986

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

114

689

1.66

6.21

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1748

15557

1.15

6.17

1.6

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

332

1.96

6.17

1.5

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

236

1678

1.42

6.08

4.4

3.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

154

1009

1.53

6.01

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

297

2199

1.36

6.01

3.7

4.3

mmol/l

3.8

3.9

0.79

280

2066

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

116

711

1.64

6.00

1.7

1.5

32.1

32.4

0.02

439

(3038515) Glucose [Moles/volume] in Venous blood

195

1345

1.46

5.93

3.7

2.9

mmol/l

7.5

7.4

0.15

190

1313

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

444

1.81

5.91

1.8

1.4

u/ml

16.1

20.4

0.59

(3006270) Folate [Moles/volume] in Blood

108

654

1.66

5.87

1.2

1.1

nmol/l

363.0

389.9

0.74

590

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

135

868

1.56

5.75

2.6

2.0

mg/l

24.8

25.4

0.04

227

(1175426) CD3 cells/100 lymphocytes in Blood

118

736

1.61

5.72

1.6

2.2

73.7

72.8

0.31

112

708

(3003740) Influenza virus B Ag [Presence] in Specimen

269

1979

1.37

5.69

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

237

1708

1.40

5.68

2.4

2.2

g/l

131.3

132.1

0.20

183

1244

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

300

2247

1.34

5.65

2.4

2.2

g/l

0.8

0.14

263

1983

(3020891) Body temperature

381

2954

1.30

5.63

4.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

616

5063

1.23

5.56

2.3

2.4

u/l

6169.6

5830.1

0.09

207

2036

(3002523) Influenza virus A Ag [Presence] in Specimen

268

1979

1.36

5.55

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

205

1447

1.42

5.54

3.7

2.8

mmol/l

1.5

0.41

200

1408

(3004451) EKG impression Narrative

319

1.92

5.45

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

127

816

1.56

5.45

1.7

1.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

115

722

1.60

5.44

1.6

2.2

10.9

14.3

1.73

381

(3003694) ABO and Rh group [Type] in Blood

2998

27750

1.11

5.42

1.6

1.5

—

(3049717) Cytology report of Urine Cyto stain

326

2489

1.32

5.41

2.4

2.6

—

(3044927) Protein electrophoresis panel - Urine

103

631

1.64

5.39

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

462

0.30

5.37

3.3

2.3

nmol/l

166.1

152.2

0.28

394

(3017315) Amylase [Enzymatic activity/volume] in Urine

473

1.74

5.36

1.4

1.3

u/l

331.3

385.2

0.22

433

(3028679) Herpes simplex virus Ab [Presence] in Serum

586

1.66

5.36

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

451

1.76

5.35

1.7

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

118

2.55

5.35

1.8

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

952

11035

0.85

5.35

1.5

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

718

6018

1.21

5.34

2.4

2.2

ug/l

6.3

7.9

1.57

636

5357

(40761539) Cells [Type] in Urine sediment by Light microscopy

200

2.15

5.29

1.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

330

1.88

5.27

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

402

1.80

5.27

1.8

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

252

1861

1.36

5.24

2.4

2.1

g/l

0.0

1.01

234

1720

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

272

2034

1.35

5.22

2.3

2.0

g/l

37.6

38.2

0.98

239

1797

(3037121) Protein [Mass/volume] in Urine

358

2784

1.30

5.20

3.0

3.3

g/l

0.3

0.60

181

1292

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

222

1608

1.39

5.20

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

222

1608

1.39

5.20

1.5

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

466

3744

1.26

5.20

1.1

u/ml

12.6

1.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

142

947

1.51

5.17

1.6

50.8

55.7

0.72

609

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

275

2064

1.34

5.15

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

249

1842

1.36

5.13

2.4

2.1

g/l

0.0

0.00

232

1718

(3017704) Immunofixation for Urine

355

1.84

5.12

1.7

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

410

3255

1.27

5.07

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

432

1.74

4.96

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

205

1480

1.39

4.92

1.1

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

268

2024

1.33

4.84

2.4

2.1

g/l

0.0

0.32

250

1877

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

106

673

1.58

4.84

1.7

2.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

399

1.76

4.81

1.8

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

209

2.06

4.76

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

372

1.78

4.72

1.6

1.5

5.5

3.9

0.34

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

105

670

1.57

4.70

1.8

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

417

1.73

4.69

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

120

790

1.52

4.68

2.7

2.1

mmol/l

4.0

0.71

120

782

(3035285) Chloride [Moles/volume] in Venous blood

120

790

1.52

4.68

2.7

2.1

mmol/l

106.3

105.3

1.68

120

782

(3033705) Calcium.ionized [Moles/volume] in Venous blood

117

768

1.53

4.63

2.7

2.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

246

1.96

4.61

1.6

1.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

368

1.77

4.59

5.0

6.5

mg/l

5354.7

1125.1

0.55

267

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

497

1.65

4.54

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

138

945

1.47

4.47

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

394

1.73

4.45

1.4

1.3

titre

54.3

71.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

109

712

1.54

4.43

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

340

2686

1.27

4.43

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

109

713

1.53

4.40

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.82

4.38

1.5

3.9

—

(3022621) pH of Urine by Test strip

632

5340

1.19

4.36

3.1

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

209

1548

1.36

4.34

1.3

1.2

u/ml

4.2

4.0

0.09

106

667

(3047007) Chlamydophila sp Ab [Presence] in Serum

201

1481

1.36

4.32

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

431

3513

1.24

4.29

1.7

—

(3000330) Specific gravity of Urine by Test strip

454

3721

1.23

4.29

3.8

3.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

109

719

1.52

4.25

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

109

719

1.52

4.25

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

199

1469

1.36

4.23

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

109

720

1.52

4.23

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

108

712

1.52

4.23

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

636

1.55

4.13

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

495

1.62

4.12

1.2

1.1

u/ml

8.3

19.7

0.56

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

605

1.56

4.11

1.2

1.1

ratio

1.0

1.1

2.22

209

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

344

1.75

4.10

1.3

1.2

g/l

0.3

0.68

282

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

3.75

4.08

1.0

1.2

—

(4034850)

350

2805

1.26

4.07

9.8

8.1

—

(3016038) Potassium [Moles/volume] in Urine

438

1.65

3.98

1.8

1.2

mmol/l

37.2

35.0

0.23

385

(3048879) Bone marrow aspiration report

191

1.99

3.91

1.6

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

103

685

1.51

3.90

1.3

1.4

e6/l

220596.8

77517.2

0.70

475

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

151

2.12

3.88

1.7

1.5

—

(4198724)

714

0.53

3.84

1.5

2.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

198

1485

1.34

3.84

1.5

1.6

—

(3021788) Differential panel - Synovial fluid

193

1442

1.34

3.84

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.84

3.78

1.2

1.5

umol/24h

362.9

328.0

0.26

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

452

3756

1.21

3.77

2.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

240

1858

1.30

3.73

1.8

1.6

e6/l

8343.1

13608.9

2.82

186

1346

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

239

1.84

3.63

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

116

2.24

3.63

1.2

1.1

pmol/l

5.1

5.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

105

713

1.48

3.63

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

207

1579

1.32

3.60

1.3

1.2

u/ml

5.2

3.3

0.83

512

(40765089) Chromosome analysis panel - Blood by G-banded

499

0.46

3.59

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

204

1554

1.32

3.58

1.5

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

130

2.16

3.56

1.5

1.7

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

7.78

3.55

2.3

2.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

197

0.25

3.51

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

151

2.06

3.50

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

316

1.71

3.49

1.2

107.1

109.9

0.39

284

(21494890) Protein electrophoresis panel - 24 hour Urine

101

687

1.47

3.48

1.7

2.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

243

1.81

3.46

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

672

1.48

3.45

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

536

1.53

3.42

1.5

1.4

ug/l

7.9

7.2

0.15

477

(3025018) Bordetella pertussis Ab [Titer] in Serum

569

1.52

3.39

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

107

2.25

3.37

1.9

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

333

2718

1.23

3.36

2.1

2.4

ug/l

227.5

635.6

2.75

298

2545

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

320

1.69

3.35

4.6

3.7

—

(3035933) Granulocytes/100 leukocytes in Blood

320

1.69

3.35

1.5

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

343

1.67

3.35

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

127

2.13

3.34

1.3

1.6

nmol/l

8.5

353278.0

1.08

107

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

247

1.78

3.30

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

121

862

1.41

3.28

1.7

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1067

9583

1.13

3.28

7.3

5.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

590

1.50

3.27

1.5

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

201

2587

0.77

3.27

1.9

3.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

248

1.78

3.26

1.1

—

(4306422)

202

1560

1.30

3.25

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

103

2.24

3.21

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

107

750

1.43

3.19

1.3

mmol/l

1.9

2.0

0.09

102

701

(3001964) Herpes simplex virus Ag [Presence] in Specimen

273

1.72

3.15

1.3

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

124

895

1.39

3.14

3.1

3.2

nmol/l

9.3

10.5

0.06

118

872

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8606

87632

0.92

3.11

3.6

mmol/l

1.3

3.82

8071

82167

(3009466) Valproate [Moles/volume] in Serum or Plasma

103

1451

0.71

3.10

4.4

5.4

umol/l

335.8

372.2

1.67

1265

(3023419) Bacteria identified in Sputum by Culture

124

897

1.39

3.10

3.0

2.6

—

(21494434) Karyotype in Bone marrow

624

1.46

3.06

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

592

1.47

3.04

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

192

1489

1.29

3.02

1.1

126.1

115.5

4.48

175

1357

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

652

5708

1.15

2.99

2.8

ng/l

184.6

163.1

0.55

582

5108

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

220

1.78

2.92

1.3

nmol/l

117.4

121.0

0.04

165

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

436

1.54

2.90

1.2

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

320

1.63

2.85

1.9

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

320

1.63

2.85

1.9

2.2

—

(4015189)

164

1.89

2.84

1.8

2.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

143

1.96

2.84

1.3

1.2

ng/l

33.1

82.1

1.34

(3011985) Renin [Units/volume] in Plasma

150

1136

1.32

2.83

1.5

mu/l

73.8

62.1

0.35

132

1027

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

293

2408

1.22

2.83

1.4

mg/l

507.3

509.9

0.03

284

2294

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

230

1.74

2.82

1.2

1.1

—

(4010399)

673

5941

1.14

2.76

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

539

1.47

2.76

1.3

1.5

u/l

5.4

6.1

0.83

460

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

145

1099

1.32

2.73

1.1

94.8

97.1

0.53

137

1033

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

324

1.61

2.73

2.0

2.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

301

1.63

2.72

2.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

135

1014

1.34

2.71

1.1

—

(3016750) Collection duration of Urine

452

1.51

2.70

2.5

2.2

min

516.0

497.7

0.84

355

(3026726) Creatinine [Moles/volume] in Specimen

2.43

2.70

1.4

2.8

umol/l

542.9

212.0

0.51

(4268621)

144

1093

1.32

2.69

2.4

2.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

226

1.73

2.69

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

600

1.44

2.69

1.6

1.8

mg/l

3.6

3.9

0.16

578

(3029075) Extractable nuclear Ab panel - Serum

272

1.66

2.67

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1420

15365

0.91

2.63

2.7

ug/l

0.7

0.99

886

9260

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

258

2113

1.23

2.61

1.3

mmol/l

3.7

0.04

242

1985

(3000012) Reticulocyte production index

368

1.55

2.60

1.3

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

120

2.00

2.60

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

139

1057

1.32

2.58

1.3

—

(3025130) Human papilloma virus identified in Specimen

177

1391

1.28

2.57

2.0

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

614

1.42

2.57

1.1

iu/ml

9.2

9.1

0.01

165

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1606

14926

1.09

2.54

2.1

2.0

—

(1761868) Lipid panel - Serum or Plasma

3529

36850

0.94

2.54

2.6

2.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9107

92351

0.93

2.51

4.3

mmol/l

2.7

2.8

18.30

8542

86671

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

468

4065

1.16

2.45

11.1

10.3

mmol/l

23.7

24.2

2.69

441

3826

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

153

1189

1.29

2.44

1.3

nmol/l

0.2

0.16

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

123

1.95

2.44

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

728

0.64

2.40

10.2

11.9

mmol/l

0.6

0.26

664

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

200

1611

1.25

2.39

1.2

1.1

au/ml

10.7

10.8

—

114

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.11

2.38

1.1

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

220

1.68

2.36

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

193

1555

1.25

2.31

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

545

6164

0.88

2.31

1.6

2.2

—

(3014271) Vancomycin [Susceptibility]

276

1.60

2.30

2.8

2.7

—

(40768446) Kidney Pathology biopsy report

404

1.49

2.29

1.8

1.7

—

(3012516) Albumin [Mass/volume] in Urine

2364

22412

1.07

2.22

3.4

3.3

mg/l

464.9

411.9

0.21

1619

14574

(21494755) Public health laboratory ask at order entry panel

1206

13026

0.92

2.17

1.3

—

(3024928) Oxygen saturation in Venous blood

208

1704

1.22

2.16

4.2

3.7

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.29

2.15

1.0

u/field

1.3

1.0

—

(3051339) Copper [Moles/volume] in Blood

2.30

2.14

1.1

1.2

umol/l

16.3

16.6

0.08

(3042111) Morphology [Interpretation] in Bone marrow Narrative

148

1169

1.27

2.13

1.5

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8953

90724

0.94

2.13

4.0

3.9

mmol/l

1.4

0.12

8430

85401

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

412

1.46

2.11

1.1

—

(3027944) Amphetamines [Presence] in Urine

545

6122

0.88

2.10

1.5

2.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.20

2.09

1.6

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

556

1.39

2.07

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

498

1.41

2.05

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.11

2.02

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.81

2.00

1.0

—

(3028300) Cannabinoids [Presence] in Urine

556

6216

0.89

1.99

1.6

2.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

279

1.54

1.99

5.2

6.2

mmol/l

24.3

24.8

0.29

262

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

510

1.39

1.98

1.3

42.0

68.4

—

(3027008) Opiates [Presence] in Urine

555

6202

0.89

1.98

1.5

2.1

—

(3022475) Manganese [Moles/volume] in Blood

2.28

1.97

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1746

16450

1.07

1.97

2.2

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

716

1.33

1.96

2.3

2.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

511

1.39

1.96

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.94

1.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.19

1.94

1.7

2.9

pmol/l

3870.4

70.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

487

1.40

1.93

1.9

1.7

147.1

139.0

0.33

457

(40761995) Spermatozoa Progressive [#/volume] in Semen

486

0.62

1.93

3.9

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

485

0.62

1.91

7.9

6.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

301

3496

0.86

1.91

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

300

3485

0.86

1.91

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

302

3506

0.86

1.91

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.96

1.89

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

297

2552

1.17

1.87

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

415

1.42

1.87

1.3

1.6

u/field

1.6

3.3

1.82

304

(3043238) Trisomy 21 risk [Likelihood] in Fetus

246

2897

0.85

1.86

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

303

3508

0.86

1.86

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.85

0.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

167

1.68

1.83

1.6

1.9

mmol/l

-1.3

0.9

1.38

159

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

101

778

1.30

1.81

1.4

1.3

nmol/l

1.5

1.4

0.40

696

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

119

1501

0.79

1.80

1.4

mmol/l

7.0

0.08

1104

(3005033) Fetal Nuchal fold Thickness US

240

2820

0.85

1.78

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

388

4400

0.88

1.78

1.5

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2457

23481

1.06

1.78

4.3

4.1

mg/mmol

8.8

9.8

0.49

1673

15401

(3047352) Trisomy 18 risk [Likelihood] in Fetus

241

2829

0.85

1.77

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

250

2130

1.18

1.77

1.6

1.5

e6/l

933.6

2986.1

0.60

203

1726

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

250

2130

1.18

1.77

1.5

e6/l

63.7

25.6

0.38

191

1632

(40768800) Prostate Pathology biopsy report

114

1439

0.79

1.75

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.33

1.74

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.33

1.74

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.33

1.74

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.33

1.74

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.33

1.74

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.33

1.74

2.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

185

1.62

1.74

1.3

1.2

pmol/l

205.6

290.1

1.31

137

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.93

1.74

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

516

5741

0.89

1.74

1.6

2.3

—

(4281824)

814

0.72

1.72

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.67

1.72

1.5

1.1

—

(3045142) Bone marrow Pathology biopsy report

105

820

1.28

1.72

1.2

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

236

2007

1.18

1.72

1.5

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

315

1.46

1.70

1.2

g/l

—

0.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

458

1.38

1.68

1.1

1.0

97.3

95.8

0.13

372

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

316

1.46

1.67

1.1

—

(3000492) Spirometry study

1051

9782

1.08

1.67

1.5

1.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.16

1.66

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1529

14434

1.07

1.65

1.7

1.8

1.4

0.85

1334

12957

(4024509)

676

1.30

1.64

1.6

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.14

1.60

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.14

1.60

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

166

1.63

1.60

2.9

4.5

u/l

89.1

43.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.33

1.60

5.4

5.9

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

113

1.77

1.60

1.2

1.4

68.0

57.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.59

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

288

1.46

1.56

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

551

1.33

1.56

1.5

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

715

6568

1.09

1.56

2.3

au/ml

24.6

22.2

0.21

438

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

675

1.29

1.53

1.2

1.3

u/ml

0.4

1.2

1.14

286

(43055514) Macroprolactin [Presence] in Serum or Plasma

335

0.60

1.53

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

100

1.80

1.52

1.1

—

(3004775) Volume in Urine collected for unspecified duration

606

1.31

1.51

2.4

2.3

788.7

642.0

1.65

434

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

138

1.67

1.51

1.7

2.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

132

1079

1.23

1.50

1.4

pmol/l

326.8

309.3

0.17

106

830

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2015

21087

0.95

1.50

3.8

3.7

21.3

21.8

0.72

904

8956

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.86

1.50

1.5

mg/l

3.3

4.9

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.86

1.50

1.5

mg/l

3.9

1.6

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.86

1.50

1.5

mg/l

1.3

2.1

0.39

(3009508) Creatinine [Moles/volume] in Urine

2694

25928

1.05

1.49

3.3

mmol/l

8.3

8.2

0.58

2330

22266

(40768806) Pleura Pathology biopsy report

666

0.72

1.49

1.5

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.07

1.49

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

478

1.34

1.48

1.4

1.7

nmol/l

1.2

0.09

373

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.43

1.47

2.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

343

1.40

1.45

1.1

1.2

114.8

107.6

0.66

312

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

187

1.55

1.45

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

489

1.33

1.44

1.8

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

226

1949

1.16

1.44

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

682

1.28

1.43

3.6

3.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

621

1.29

1.42

2.3

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

657

6046

1.09

1.40

1.3

au/ml

59.9

47.2

0.58

242

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

329

1.40

1.2

99.2

90.2

0.96

153

(3019977) pH of Arterial blood

397

1.36

1.40

2.7

2.8

7.4

0.24

124

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.61

1.36

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

430

4754

0.90

1.35

1.6

2.4

—

(40768795) Lymph node Pathology biopsy report

101

813

1.24

1.35

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

216

1867

1.16

1.35

2.3

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

335

3755

0.89

1.35

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

340

1.38

1.35

1.1

100.2

91.9

1.85

154

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.75

1.34

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.04

1.32

1.5

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

148

1755

0.84

1.31

1.2

1.3

ug/l

2.3

3.8

4.91

138

1594

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

658

1.26

1.28

2.5

3.1

—

23.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.89

1.28

2.0

5.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

669

0.75

1.27

1.4

1.5

e6/l

15743.5

54111.8

2.56

394

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

431

1.32

1.26

1.6

2.1

umol/l

79.0

143.4

2.31

215

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

242

0.58

1.25

1.4

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

2.40

1.24

1.2

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

304

1.38

1.22

1.0

1.2

58.7

14.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

556

1.28

1.22

1.8

2.8

36.1

40.0

0.50

194

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

220

1922

1.15

1.22

1.4

1.5

pmol/l

59.5

124.5

6.26

214

1871

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

296

2637

1.13

1.22

1.9

pmol/l

204.1

201.1

0.19

284

2516

(3016135) IgD [Mass/volume] in Serum

2.63

1.21

1.0

1.2

mg/l

36.6

75.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

124

1.61

1.20

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

437

3983

1.10

1.19

1.3

miu/ml

225.3

222.6

0.05

177

1874

(3036670) Protein [Mass/volume] in Synovial fluid

189

1.48

1.18

1.3

1.2

g/l

37.4

39.8

0.55

106

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

117

1.62

1.17

1.8

2.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.93

1.16

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

231

1.43

1.16

1.2

1.1

—

(3024263) Appearance of Synovial fluid

429

1.31

1.15

1.9

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

136

1151

1.18

1.15

1.6

—

(3045788) Cell count panel - Pleural fluid

588

0.75

1.14

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

622

0.75

1.14

1.9

1.6

—

(3036603) Volume of Urine

536

1.27

1.13

1.8

1.7

1701.8

2122.1

0.84

109

(3040151) Glucose [Moles/volume] in Capillary blood

103

852

1.21

1.12

6.0

13.5

mmol/l

6.8

7.4

0.85

715

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

370

1.33

1.12

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

114

0.44

1.12

1.2

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

225

1.42

1.11

1.2

77.7

83.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.26

1.10

1.4

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

209

1.44

1.10

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

209

1.44

1.10

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

209

1.44

1.10

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

209

1.44

1.10

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

549

0.75

1.09

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.38

1.09

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.95

1.08

1.3

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

194

0.57

1.08

1.9

2.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

171

1967

0.87

1.08

1.5

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.87

1.07

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

747

0.79

1.04

1.2

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

723

1.22

1.04

1.0

1.1

u/ml

4.1

1.2

0.49

197

(3049242) von Willebrand panel - Platelet poor plasma

2.27

1.03

1.6

1.5

—

(4211845)

428

1.29

1.03

2.9

2.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

437

1.28

1.03

2.0

2.4

ug/l

25.1

134.5

0.94

411

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.69

1.01

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9054

91271

0.96

1.00

4.1

4.0

mmol/l

4.6

4.7

15.17

8558

86204

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

205

1.42

1.00

1.4

1.3

42.9

37.9

0.35

133

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.62

0.99

2.4

2.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

730

0.79

0.99

1.7

2.4

—

(3047189) Immunofixation for 24 hour Urine

326

1.32

0.98

1.6

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.84

0.98

1.4

1.7

umol/l

39.0

42.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

6.2

—

0.2

—

(3044941) Cell count panel - Synovial fluid

142

1227

1.16

0.97

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

141

1628

0.86

0.97

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

597

5577

1.07

0.96

1.4

iu/l

26.3

25.4

0.25

521

4757

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.74

0.96

1.1

u/l

28.7

9.9

0.39

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.74

0.96

1.4

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.89

0.94

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.89

0.94

2.1

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

225

1.38

0.94

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

225

1.38

0.94

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

225

1.38

0.94

1.1

—

(3036180) Methadone [Presence] in Urine

2.22

0.93

1.0

2.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

192

1.41

0.92

9.9

5.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

226

1.37

0.92

1.2

72.0

76.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

339

1.30

0.91

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2337

22674

1.04

0.91

1.7

1.6

mmol/l

1.4

0.46

1995

19472

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.14

0.91

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.67

0.91

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

184

1.41

0.91

1.2

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

110

938

1.17

0.90

3.1

2.9

nmol/l

0.8

0.06

688

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

536

1.23

0.90

1.1

nmol/l

1.3

8.2

1.30

106

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.75

0.90

1.2

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

193

1.40

0.90

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.38

0.90

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

332

1.30

0.88

1.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

367

3377

1.09

0.88

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

751

0.81

0.88

1.4

1.5

e6/l

2685.7

2588.9

0.06

536

(3011288) Drugs identified in Urine by Screen method

379

4108

0.92

0.88

2.0

3.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

622

5843

1.07

0.87

3.3

pmol/l

4.5

4.6

0.28

557

5265

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.00

0.87

1.0

—

(3008295) Osmolality of Serum or Plasma

795

1.18

0.86

1.3

1.5

mosm/kgh2o

278.6

282.2

0.69

618

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.72

0.86

1.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

108

925

1.17

0.85

1.4

mmol/l

10.7

11.8

0.65

211

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

102

870

1.17

0.85

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

124

1076

1.15

0.84

1.6

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

622

6603

0.94

0.83

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

231

1.34

0.82

2.4

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

231

1.34

0.82

2.4

2.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

249

0.68

0.81

1.8

2.1

umol/l

16.8

16.5

0.04

249

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.64

0.81

1.3

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

318

0.72

0.80

1.9

2.9

umol/l

27.6

28.4

0.14

228

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

347

1.27

0.79

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

365

1.26

0.79

1.2

1.1

ng/l

108.4

286.7

0.88

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

114

1.49

0.79

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

114

1.49

0.79

1.3

1.4

—

97.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

385

0.75

0.79

1.9

2.1

ug/min

82.8

174.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

146

1290

1.13

0.78

1.2

1.3

u/l

43.7

35.0

0.23

134

1130

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

115

1.48

0.76

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

1.50

0.76

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

103

891

1.16

0.75

4.0

4.9

u/ml

62.0

70.3

0.14

287

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.57

0.74

1.2

1.1

—

(3034426) Prothrombin time (PT)

369

1.25

0.74

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

164

1466

1.12

0.74

1.2

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

208

0.67

0.73

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

134

0.60

0.73

1.4

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

424

1.23

0.72

1.8

2.4

14.0

10.3

1.48

403

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

108

0.56

0.72

1.2

3.0

umol/l

27.8

42.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

128

1130

1.13

0.71

1.1

—

13.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

134

1.42

0.71

1.0

1.1

u/ml

0.0

0.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

103

896

1.15

0.71

1.0

1.1

mg/l

224.1

254.1

1.57

800

(3017509) Phencyclidine [Presence] in Urine

170

0.65

0.70

1.2

1.7

—

(3002619) Bacteria identified in Specimen by Culture

160

1.38

0.70

1.5

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

143

1.40

0.70

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.71

0.70

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

169

1.36

0.69

1.1

1.7

ug/l

1.2

2.1

2.71

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1010

9699

1.05

0.69

3.9

4.0

32.6

31.5

2.26

777

6951

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

196

1779

1.10

0.68

1.7

2.3

nmol/l

1.0

0.8

1.71

167

1515

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.85

0.68

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.68

1.3

—

(3006462) Nitrate [Presence] in Urine

392

1.23

0.67

2.9

2.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

120

0.58

0.67

1.0

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.63

0.66

1.0

1.1

u/l

204.6

517.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.54

0.66

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

420

1.22

0.66

1.8

1.9

—

(3020650) Glucose [Presence] in Urine

276

1.27

0.66

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.57

0.65

2.3

2.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

171

1547

1.11

0.65

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.47

0.64

1.2

mmol/l

0.7

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

913

0.86

0.63

1.8

2.2

nmol/l

21.4

20.1

0.57

867

(40758292) HTLV I+II Ab panel - Serum

181

1.33

0.63

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

225

1.29

0.62

1.8

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

891

0.86

0.62

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

102

0.59

0.62

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

692

1.16

0.62

1.7

1.8

mmol/l

6.9

6.4

0.77

513

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

748

1.15

0.62

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

226

1.28

0.61

1.1

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

130

1.39

0.61

6.1

6.9

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.60

0.0

1.0

—

27.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

453

1.19

0.60

1.0

ng/l

314.7

313.1

0.01

328

(3003434) Protein [Mass/volume] in Pleural fluid

822

0.86

0.59

1.4

1.5

g/l

34.1

34.3

0.03

741

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.44

0.58

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

114

1.40

0.58

8.7

9.6

mmol/l

5.4

5.9

0.19

114

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

162

0.68

0.58

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

355

1.21

0.57

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

355

1.21

0.57

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

567

1.16

0.57

1.9

u/field

1.4

1.8

0.67

255

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.67

0.56

1.0

1.3

nmol/l

450.5

544.9

—

(3000060) B lymphocytes [#/volume] in Blood

310

1.23

0.56

1.7

2.4

e6/l

261.3

260.1

0.00

160

(3008536) Aspergillus sp Ab [Presence] in Serum

167

1.32

0.56

2.2

2.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.45

0.56

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

104

925

1.13

0.56

1.1

1.2

mg/l

39.4

41.3

0.18

780

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

550

1.16

0.55

5.6

6.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

373

0.80

0.54

1.1

—

(40757373) Influenza virus identified in Isolate

151

1.33

0.53

1.3

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

165

1510

1.09

0.53

1.3

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.43

0.52

2.1

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

178

1.29

0.52

1.1

—

(4027681)

722

1.14

0.52

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.52

0.52

1.2

1.1

—

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.50

0.51

2.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.47

0.50

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

153

1.31

0.50

1.3

1.1

umol/24h

0.6

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

454

1.17

0.49

1.0

ng/l

770.7

745.4

0.18

321

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

334

1.20

0.49

2.2

2.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

726

1.13

0.49

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.43

0.49

1.3

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.45

0.48

1.0

u/ml

0.1

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

456

1.16

0.47

1.0

ng/l

36.7

42.7

0.60

323

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.46

0.46

1.0

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

155

1.29

0.46

2.0

2.2

mmol/l

9.4

7.8

0.60

(3051101) Glucose [Moles/volume] in Cord blood

118

0.68

0.45

4.5

6.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

864

1.11

0.45

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

165

1.27

0.44

1.0

1.5

g/l

26.4

24.8

0.17

123

(3042517) Benzodiazepines panel - Urine

174

1.26

0.44

1.7

2.7

—

(3051593) INR in Capillary blood by Coagulation assay

275

1.20

0.43

3.2

8.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

322

1.18

0.42

1.0

1.1

u/ml

0.3

5.8

1.46

184

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.40

0.42

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

10263.0

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.41

0.0

1.8

—

7.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

437

4563

0.96

0.41

1.5

1.6

mu/l

281.0

297.7

0.59

395

4132

(44806420)

161

0.75

0.41

2.4

2.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

177

1.24

0.40

1.3

mu/l

40.0

96.4

0.76

143

(3024869) Neuronal Ab [Presence] in Serum

149

0.74

0.40

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

115

1.30

0.38

1.2

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

399

3821

1.05

0.38

1.7

1.8

nmol/l

39.2

39.0

0.05

391

3734

(3022689) Creatine [Moles/volume] in Urine

269

0.82

0.38

2.5

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

197

1.22

0.37

1.2

1.4

g/l

12.0

13.2

0.19

148

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

279

0.82

0.37

1.7

1.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

987

0.91

0.37

1.5

1.6

mmol/l

7.4

7.7

0.54

598

(3012441) Differential panel - Pleural fluid

650

0.89

0.35

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

892

9158

0.97

0.35

2.1

2.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

868

8451

1.03

0.35

2.2

nmol/l

13.1

13.0

0.18

795

7606

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.62

0.35

1.4

1.2

umol/24h

1.6

2.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

153

1.24

0.35

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

394

3782

1.04

0.35

1.4

u/l

8.3

8.6

0.20

325

3092

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

511

0.88

0.34

5.0

6.9

u/ml

30.7

5974.7

—

123

(3020191) Ethanol [Moles/volume] in Serum or Plasma

928

0.92

0.33

1.8

1.5

promille

1.1

1.4

0.89

701

(3001893) Eosinophils/100 leukocytes in Pleural fluid

182

1.21

0.33

1.3

1.5

4.5

3.0

0.23

159

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

297

3100

0.96

0.31

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

456

1.12

0.31

1.1

u/ml

29.8

9.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1092

11152

0.98

0.31

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.31

0.30

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

358

3451

1.04

0.28

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

737

1.09

0.28

1.0

1.1

u/ml

0.9

2.1

0.82

180

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

223

1.17

0.28

1.3

1.5

38.3

64.0

2.89

184

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.27

0.27

1.6

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

168

1.19

0.27

1.3

1.2

ug/l

12.7

185.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8648

86771

0.99

0.26

4.0

mmol/l

5.8

0.64

8026

80632

(44813793)

702

1.08

0.26

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

562

0.91

0.26

1.4

mmol/l

5.3

5.5

0.85

533

(3050794) Legionella sp Ab [Presence] in Serum

1.30

0.26

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

686

7024

0.98

0.26

1.2

iu/ml

88.1

146.8

5.78

238

2728

(4094501)

238

2283

1.04

0.25

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

192

0.83

0.25

1.6

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

127

0.79

0.25

1.0

1.4

—

(3025315) Body weight

1.22

0.25

6.1

3.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

100

1067

0.94

0.25

1.3

pmol/l

81.3

101.2

0.26

300

(44806071)

142

1.20

0.24

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

198

1.16

0.24

1.1

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

684

0.92

0.24

2.7

3.6

mu/l

38.2

30.5

0.57

644

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

133

1.20

0.24

11.8

7.1

60.3

70.9

0.63

107

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

212

0.85

0.24

1.1

u/ml

0.1

6.4

1.63

156

(3019832) Treponema pallidum Ab [Presence] in Serum

1311

13308

0.98

0.23

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

172

1799

0.96

0.22

4.3

3.1

mg/l

22.0

26.2

1.17

106

1116

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.25

0.22

10.2

10.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

153

1.18

0.22

1.7

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.22

0.22

1.0

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.22

0.22

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

191

1.15

0.21

1.3

1.7

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

169.5

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.5

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

6.6

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

238

2465

0.96

0.20

1.1

u/ml

1.6

1.7

0.08

1038

(3023487) Leukocytes [#/volume] in Peritoneal fluid

272

0.88

0.20

2.1

2.2

e6/l

803.8

3738.2

0.51

188

(3003888) Timothy IgE Ab [Units/volume] in Serum

215

2231

0.96

0.20

1.1

u/ml

7.4

6.6

0.24

1224

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

145

1.17

0.20

2.5

1.6

ng/l

110.7

127.9

0.22

145

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.20

0.0

1.1

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

572

5842

0.98

0.20

1.2

—

(3019174) dRVVT (LA screen)

1.21

0.19

1.0

1.2

—

(4038314)

132

0.83

0.18

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.21

0.18

1.3

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

607

6185

0.98

0.18

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.17

0.17

1.0

—

(3023410) Appearance of Cerebral spinal fluid

1010

0.95

0.17

1.9

1.7

—

(3017569) Oxygen content in Arterial blood

310

1.10

0.17

2.9

2.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.14

0.16

1.1

1.2

mg/l

6.2

11.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

160

1658

0.96

0.16

1.1

u/ml

7.6

5.4

0.54

712

(3045716) Anion gap in Serum or Plasma

331

1.09

0.16

3.0

2.5

mmol/l

8.4

9.2

0.61

250

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

206

1.12

0.16

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

235

2284

1.03

0.15

1.9

iu/l

3.4

4.3

1.40

882

(3033799) Differential panel - Peritoneal fluid

236

1.10

0.14

2.2

2.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

567

1.06

0.14

1.6

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

160

0.87

0.14

7.5

6.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

626

1.05

0.14

1.3

umol/l

3.4

5.6

6.80

583

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

243

0.91

0.13

2.1

1.9

e6/l

7364.1

15937.4

0.43

129

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

218

1.10

0.13

8.8

6.9

—

(40768793) Breast Pathology biopsy report

167

1719

0.97

0.13

1.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

206

2113

0.97

0.12

1.1

u/ml

2.9

2.4

0.16

535

(3038071) Oxygen [Partial pressure] in Mixed venous blood

200

0.90

0.12

9.2

7.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

272

0.92

0.12

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

346

1.07

0.12

3.3

2.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

346

1.07

0.12

3.0

2.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

178

1734

1.03

0.11

1.4

u/l

23.6

23.0

0.11

151

1440

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

718

7265

0.99

0.11

1.9

—

(4133840)

312

0.93

0.11

1.3

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

353

0.93

0.11

1.0

—

(1002224) Polysomnography panel

476

4697

1.01

0.10

1.1

—

(3044007) Cell count panel - Peritoneal fluid

218

0.92

0.10

2.5

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

176

1721

1.02

0.09

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.09

0.09

1.2

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.09

0.09

5.0

3.4

—

(3000034) Microalbumin [Mass/volume] in Urine

765

1.03

0.08

3.5

3.0

mg/l

44.3

67.3

0.45

564

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.78

0.08

1.2

u/ml

1.6

5.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.03

0.07

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.84

0.07

1.8

5.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

327

0.95

0.07

1.5

pmol/l

14.7

14.9

0.07

277

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

423

4184

1.01

0.07

2.1

3.1

u/ml

44.0

42.5

0.04

408

4047

(3014133) Dog dander IgE Ab [Units/volume] in Serum

176

1792

0.98

0.07

1.1

u/ml

3.0

4.8

1.19

729

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

183

1862

0.98

0.07

1.4

1.5

nmol/l

0.4

0.04

150

1493

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.86

0.07

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.85

0.07

2.1

2.3

u/field

0.0

0.6

—

(3014891) Appearance of Pleural fluid

0.84

0.07

2.0

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.07

0.07

1.3

u/l

26.6

500.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

244

2408

1.01

0.06

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

750

1.03

0.06

1.5

2.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

105

1028

1.02

0.06

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

284

2869

0.99

0.05

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

584

1.03

0.05

1.4

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2642

26487

1.00

0.05

4.2

ug/l

2.1

2.7

1.85

2399

24090

(3044009) aPTT.lupus sensitive (LA screen)

1.10

0.04

1.0

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

378

1.03

0.04

1.1

u/ml

14.0

10.2

—

(4146454)

746

1.02

0.03

2.4

2.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

145

1467

0.99

0.03

1.0

1.1

u/ml

0.6

0.5

0.03

330

(3035880) pH of Pleural fluid

341

0.97

0.03

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

211

2128

0.99

0.03

1.1

u/ml

1.7

1.3

0.17

947

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8118

81226

1.00

0.03

5.1

5.0

mmol/mol

38.5

38.9

3.30

7639

76392

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

193

1914

1.01

0.03

2.8

2.4

ug/min

78.0

124.9

1.20

115

1226

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

239

0.96

0.02

1.4

2.4

ng/l

126.1

123.4

0.03

140

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

127

0.94

0.01

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

387

0.98

0.01

2.1

2.0

ug/l

2.0

3.4

1.80

341

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

141

1402

1.01

0.01

1.8

1.9

titre

8032.0

2339.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

205

2056

1.00

0.00

1.8

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

103

0.97

0.00

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

536

1.01

0.00

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

616

1.01

0.00

1.1

u/l

1.0

0.17

281

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

125

0.96

0.00

1.0

u/ml

1.0

0.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

135

0.96

0.00

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

135

0.96

0.00

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

155

0.97

0.00

1.0

1.3

mg/l

0.3

84.1

—

115

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

424

4243

1.00

0.00

2.0

1.9

—

(3001556) Androgen free Index in Serum or Plasma

165

1.03

0.00

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

185

1.03

0.00

1.1

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

170

1696

1.00

0.00

2.1

titre

13.0

7.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

695

0.99

0.00

1.0

u/ml

0.2

1.4

—

104

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

162

1615

1.00

0.00

1.1

iu/ml

25.4

6691.5

0.65

405

(3016273) Islet cell 512 Ab [Units/volume] in Serum

102

0.98

0.00

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

178

1.01

0.00

1.7

1.5

nmol/l

0.2

0.06

135

(40757494) Bilirubin.total [Moles/volume] in Blood

432

1.00

0.00

2.3

2.4

umol/l

12.3

19.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

429

1.00

0.00

1.5

1.6

nmol/l

3.6

9.4

0.49

353

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

109

1.01

0.00

3.2

3.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

23.4

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3001729) Color of Synovial fluid

1.00

0.00

1.5

1.6

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.8

—

(3000285) Sodium [Moles/volume] in Blood

0.96

0.00

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.91

0.00

3.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.94

0.00

1.4

3.1

—

0.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.02

0.00

5.0

3.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.89

0.00

1.0

1.3

ug/l

80.6

137.3

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

11.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.0

—

12.9

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.97

0.00

1.4

75.2

71.7

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3018487) Sunflower Seed IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.86

0.00

1.4

1.2

—

(4212803)

0.95

0.00

1.2

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.95

0.00

1.0

1.6

pmol/l

5.6

14.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_KELAIBD and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_KELAIBD	1.182 [1.05, 1.33]	0.005
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 1248 out of 20102 females with K11_KELAIBD died.

Males

Parameter	HR [95% CI]	p-value
K11_KELAIBD	1.016 [0.92, 1.12]	0.756
Birth year	0.99 [0.98, 1.0]	0.053

During the follow-up period (1.1.1998 — 31.12.2019), 1842 out of 23160 males with K11_KELAIBD died.

Mortality risk

Mortality risk for people of age

years, who have K11_KELAIBD.

N-year risk	Females	Males
1	0.066%	0.24%
5	0.49%	1.366%
10	1.328%	3.195%
15	2.437%	6.092%
20	4.375%	10.619%

Relationships between endpoints

↥

Index endpoint: K11_KELAIBD – IBD patients in KELA-register

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

IBD patients in KELA-register

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints